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ABSTRACT 
 Even though patient counselling is considered one of the main duties for community pharmacists, 
studies have indicated that there is room for improvement in counselling performance. In order to 
enhance patient counselling practise in Finland, a four-year project TIPPA was launched in 2000. A need 
for patient counselling specific instruments became evident in order to implement new behaviours and to 
evaluate existing counselling practices. 
 The aim of this study was to develop instruments to measure the quality of patient counselling. The 
process was started with a validation of the United States Pharmacopeia (USP) Medication Counselling 
Behaviour Guidelines. The construct validity and internal consistency of the Guidelines were evaluated 
by conducting factor analysis and assessing Cronbach's alpha. The statistical analysis indicated that the 
Guidelines are a valid and reliable instrument. The next step was to assess their usefulness among Finnish 
pharmacy practitioners 2,5 years after the TIPPA had started by sending a questionnaire to a random 
sample of community pharmacists (response rate 51%, n=376). More than one quarter (27%) of the 
respondents were aware of the Guidelines. The Guidelines were made known to the respondents mostly 
via a book on patient counselling skills (41% of those knowing the Guidelines), continuing education 
(37%), and in-house training (28 %). Over 60% of those who knew about the Guidelines regarded them as 
a good or very good instrument for learning the principles of patient counselling. The applicability of the 
Guidelines as an instrument for self-evaluation of performance in different settings was considered less 
useful.  
Factors related to the quality of patient counselling were determined as part of the training of ten external 
auditors of counselling practices. A modified Delphi method was used, with two expert panels: Panel 1, 
consisting of experienced pharmacy practitioners (n=10), and Panel 2, consisting of academic and 
professional experts (n=10). The final consensus was assessed by a Delphi questionnaire round (response 
rate 74%, n =26). The first Delphi round yielded a high consensus, the level of agreement varying 
between 69% and 100%. All the items except one met the predefined criteria for approval. A total of 16 
indicators were identified in three quality dimensions: Customer (4 indicators); Process (6 indicators); and 
Learning and Innovations (6 indicators). Strategy and vision of the pharmacy in patient counseling 
formed the core of the instrument.  
 A pseudo customer method that takes into account the professional content of counselling was 
developed to assess patient counselling practices in community pharmacies during the project. 
Counselling practices were annually evaluated in sixty selected community pharmacies by using four 
different scenarios (three self-medications and one prescription). The scoring criteria were based on the 
USP Guidelines and were divided into two categories: Needs Assessment and Instructions for Use. Two 
out of the four scenarios used showed a statistically significant increase between the baseline and the final 
follow-up. The results of the national pseudo customer studies indicate that more emphasis should be paid 
to customers asking for a self-medication product by a brand name and to customers with repeat 
prescriptions.  
 The instruments developed in this study can be used in the evaluation of counselling practices at 
different levels. At the organisational level, the patient counselling quality assurance instrument can be 
used in conducting a present state analysis of counselling practices and constructing a long-term 
development plan. The quality assurance instrument can also be used in an external auditing process of 
counselling practices. The pseudo customer method can be applied at the organisational and national level 
to assess counselling performances. Individual pharmacists can use the USP Guidelines in self-evaluation 
and peer-evaluation of counselling practice. In order to implement good quality patient counselling 
practices, current practices need to be evaluated in a wider perspective than the customer-pharmacist 
interaction. 
National Library of Medicine Classification: W 85, QV 737 
Medical Subject Headings: community pharmacy services; pharmacies; pharmacists; patient education; 
directive counselling; quality of health care; self-care 
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 OPERATIONAL DEFINITIONS OF THE KEY TERMS 
 
Audit 
Examination and review of activities. Audit can be divided into three types: self audit 
(self-evaluation), peer audit (peer-evaluation) and external audit. Self and peer audit 
involve an individual or group auditing their own performance against published 
standards or personal objectives. External audit occurs when visiting experts audit the 
practice. 
 
Community pharmacy 
A health care unit specialised in medicines. In Finland, the owner must have a Master’s 
degree in pharmacy. A community pharmacy has many obligations, the most important 
of which is to ensure that medicines needed by the local inhabitants are always available 
and used safely.  
 
Organization 
Consists of a group of individuals working towards shared goals, whose behaviour is 
modified by rules and structure (Scott 1998).  
 
Patient counselling 
An approach that focuses on enhancing problem-solving skills of the patient for the 
purpose of improving or maintaining the quality of health and the quality of life. The 
process emphasises that the health professional provides and discusses medication 
information with the appropriate person to achieve this goal. Counselling is based on the 
individual patient’s needs. The nature of the relationship between the patient and health 
care provider is interactive and constitutes a collaborative learning process for both 
parties (United States Pharmacopeia). 
 
Peer-evaluation 
A process where the evaluation of actions and performance is conducted by a peer. 
 
 Pharmacist 
A health care professional specialised in medicines. According to the Medicines Act in 
Finland, the main duty of a pharmacist is to dispense medicines and to ensure their safe 
and proper use among the public. In Finland, there are two pharmaceutical degrees: 
Master’s degree (5-year education at the university) and Bachelor’s degree (3-year 
education at the university).  
 
Quality assurance 
Activities that assure the acceptable levels of quality (Øvretveit 1992).  
 
Reliability 
Reliability assesses reproducibility or stability of data. The methods of testing for 
reliability include multiple forms; basic tests of internal consistency, test-retest, intra-
rater and inter-rater agreement.  
 
Self-evaluation 
A process where the aim is to evaluate one’s own actions and performance. 
 
Service quality 
Service quality is a measure of how well the service level delivered matches customer 
expectations. Customers assess service by comparing the service they receive 
(perceptions) with the service they desire (expectations) (Berry et al. 1990). 
 
Validity 
A valid measure is one that measures the construct that it is intended to measure. 
Validity is inferred from the manner in which a scale is constructed, its ability to predict 
specific events, or its relationship to measure other constructs. 
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1 INTRODUCTION 
 
   “I should get used to doing self-evaluation and  
     peer-evaluation in daily practice” 
    Community pharmacist responding to survey  
 
 
 Changing existing practices and behaviour patterns in health care have proved to be 
challenging (Haines and Jones 1994, Armstrong et al. 1996, Grol 1997). Even though 
patient counselling has long been considered a main duty for community pharmacists 
and this role has more recently received strong promotion from the profession, changes 
in actual performances have been moderate (De Young 1996a, Morris et al. 1997, 
Erickson et al. 1998, Rutter et al. 2004). Studies assessing counselling practices have 
mostly been cross-sectional and focused on individual factors affecting counselling 
practices (Blom et al. 1988, Laurier and Poston 1992, Schommer and Wiederholt 1997). 
Research has indicated that no single factor can explain counselling performance 
therefore there is a need to use a series of different strategies to promote a change 
among community pharmacists (Kimberlin et al. 1993, Odenina et al. 1995, Farris and 
Schopflocher 1999, Roberts et al. 2003).  
 Also, the role of the patient has shifted from passive information recipient to an 
active information gatherer and partner in medication use (Chewing and Sleath 1996). 
Compliance and adherence were the terms used in describing a patient’s drug taking 
behaviour. The new philosophy of concordance challenges health care professionals and 
patients to take a more active role in medication use (Bond 2004).  Concordance is 
fundamentally different from compliance or adherence: i) it focuses on the consultation 
process between the patient and the health care professional, and ii) it is based on a 
notion that this consultation is a negotiation between equals (Marinker and Shaw 2003, 
Stevenson et al. 2004). Therefore, systematic and long-term development processes 
are needed at the pharmacy level in order to promote a shift towards two-way 
communication and new counselling practices. In this process, pharmacists need 
concrete measures and tools to evaluate and assess their counselling practices. 
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Pharmacies as organisations should be able to measure their activities, and these 
measures should be applicable to different kind of audits and assessments. However, 
there is a lack of reliable and valid measures applicable for community pharmacy 
settings.  
  The aim of the current study was to develop instruments to measure the quality of 
patient counselling during the national TIPPA project (2000–2003). The abbreviation 
TIPPA stands for the Finnish words “Customized Information for the Benefit of the 
Patient from the Community Pharmacy”. The process was begun by validating the 
United States Pharmacopeia Medication Counselling Behaviour Guidelines. Their 
usefulness was assessed among Finnish community pharmacists two and half years after 
the TIPPA project had started. A comprehensive quality assurance instrument was 
developed as a part of the training of ten external auditors (known as TIPPA tutors). 
Finally, a pseudo customer method was developed to assess counselling practices in 
sixty Finnish community pharmacies over the four-year period. 
 In this dissertation, I have mainly focused on counselling in the context of community 
pharmacy even though counselling takes place also in other settings such as in hospitals 
and clinics. The quality of patient counselling is viewed from an organisational and 
from an individual pharmacist perspective.  
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2  CONTEXT OF THIS STUDY 
 
2.1 Finnish pharmacy system 
 
 In Finland, medicines (both prescription and non-prescription medicines) are sold to 
the public only from community pharmacies. Finland has a privately owned pharmacy 
system with 605 pharmacies and altogether 802 outlets covering the whole country 
(Table 1). There are two exceptions of the privately owned pharmacies: Helsinki 
University Pharmacy owned by the University of Helsinki and Kuopio University 
Pharmacy owned by the University of Kuopio. Helsinki University Pharmacy consists 
of 17 outlets in Helsinki and some other urban communities. Kuopio University 
Pharmacy has one outlet in Kuopio.  
 The pharmacy business in Finland is regulated by the government (National Agency 
for Medicines) that controls the location, number and ownership of pharmacies. The 
prices of medicines are the same in all community pharmacies. The sale of medicines 
(prescription and non-prescription medicines) constitutes 95% of the turnover of the 
pharmacies (The Association of Finnish Pharmacies 2005).  
 
Table 1.  Core characteristics of Finnish pharmacies (2004). 
Number of outlets 802 (605 main pharmacies and 197 subsidiaries) 
Average annual prescription volume 60 470 
Prescriptions/inhabitant 7.8 
Population/pharmacy ratio 1: 6 500 
Average annual turnover 2.9 million euros 
Average number of pharmacists/pharmacy 7 
Source: The Association of Finnish Pharmacies and Pharma Industry Finland 
 
 The personnel in Finnish pharmacies consists of the pharmacy owner and staff 
pharmacists with a Master’s degree, pharmacists with a Bachelor’s degree and 
technicians with varying educational backgrounds. Approximately 60% of the pharmacy 
personnel have a pharmaceutical education. The owner of a pharmacy must have a 
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Master’s degree. Only personnel with a degree in pharmacy are allowed to serve and 
advise customers.  
 In Finland, pharmacy services have been studied in the field of social pharmacy since 
the 1980s. Studies have shown that customers are satisfied with community pharmacies 
and they wish to have professionally oriented pharmacy services (Airaksinen 1996, 
Väisänen 2003). However, customers want more information especially on 
pharmacotherapeutic issues such as side-effects and interactions, while pharmacists 
place a priority on information concerning drug dosage, storage and duration of medical 
treatment (Airaksinen et al. 1994). Furthermore, customers appreciate and want 
counselling whereas pharmacists often assume the opposite (Airaksinen et al. 1994, 
Airaksinen 1996, Katajavuori et al. 2002). 
 Since 1983, according to the Pharmacy Act (4/1928), it is the duty of community 
pharmacists to ensure that customers know how to use their medicines properly and 
safely. Since 1988, pharmacies have been mandated to provide facilities to supply 
privacy for patient counselling. Prior to 1983, community pharmacists were not allowed 
to give information to patients unless they asked for it, and even then, the content was 
limited (Vainio 2004). The professional role of a community pharmacist has changed 
since the mandate to counsel was introduced in 1983. Today, most Finnish pharmacists 
perceive their work as that of a drug expert (Savela 2003). Even though the perception 
of the professional role has fundamentally changed, old traditions such as a 
misconception that customers do not want information, were still reflected in 
counselling practices in community pharmacies in the mid (Vainio 2004) and late 1990s 
(Katajavuori 2005).   
 
2.2 Professional development in community pharmacies 
 
 In order to support the professional development of community pharmacies, the 
Association of Finnish Pharmacies established a national strategy in 1997 (The 
Association of Finnish Pharmacies 1997). The strategy achieved a wide consensus 
among the profession and the key stakeholders. According to that strategy, pharmacies 
compete with their services not with their prices; there is always a pharmacist to serve 
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and counsel patients; and when medicines (both prescription medicines and non-
prescription) are sold information is always provided. Furthermore, community 
pharmacies take part in national health promotion activities together with other health 
care professionals. Professional long-term programmes in community pharmacies focus 
on chronic diseases such as asthma and diabetes (Ministry of Social Affairs and Health 
et al. 1997, The Association of Finnish Pharmacies and Finnish Diabetes Association 
2001). A professional programme focusing on heart diseases will be launched in 2005. 
The aim of these programmes is to develop the competence of pharmacy staff so they 
can better guide patients and to encourage local cooperation with other health care 
professionals. 
 In Finland, there has been a long-term co-operation between professional bodies, 
pharmacy schools and authorities to promote a change in patient counselling practices. 
The first systematic joint attempt was the World Health Organisation EuroPharm 
Forum’s “Questions to Ask About Your Medicines” public awareness campaign in 
1993–1996 (Airaksinen et al. 1998, Vainio et al. 2002). The evaluation of the program 
was conducted by an observational method with measurements at baseline, and three 
and twelve months after starting the campaign. The results showed improvement in i) 
customizing the information, and ii) showing empathy to the patients, but iii) did not 
improve the content of information or the frequency of counselling (Airaksinen et al. 
1998). It was understood that community pharmacists need concrete instruments to 
evaluate and develop counselling practices. In 1998, the Association of Finnish 
Pharmacies conducted a pseudo customer study to assess counselling performances and 
to assess the implementation of the professional strategy (The Association of Finnish 
Pharmacies 1998, unpublished). The results indicated that there was room for 
improvement and as a consequence, a four-year, joint project TIPPA was launched in 
2000. 
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3  PATIENT COUNSELLING AS A CONCEPT OVER TIME 
 
 Patient counselling and advice-giving are terms used in the literature to describe the 
communication between pharmacists and patients. The term advice-giving is used 
mostly in the British literature (Raynor 1996). However, there is no clear consensus 
about these concepts and what constitutes good counselling performance. It appears that 
pharmacy practice researchers have either omitted or offered sketchy definitions of 
these key terms (Kirking 1982, De Young 1996b, Raynor 1996).   
 
3.1 Definitions used in the literature 
 
 Some researchers have tried to conceptualize the term patient counselling in their 
studies. One of the earliest definitions was presented by Puckett et al. (1978) as “any 
oral or written communication (including auxiliary labels) from the practitioner relating 
to the drug product and its use”.  This statement was supported by Ross et al. (1981). 
Kirking (1982) defined patient counselling as “the provision of verbal information that 
will help patients to use their medications properly”. Holland (1992) defined 
counselling as “the process of giving professional advice about medicines and other 
health matters”. According to Schommer and Wiederholt (1994a), “patient counselling 
is the provision of advice that is the reasoned opinion of a pharmacist, is subjective, and 
is patient-oriented within a medication-taking context”. Aslanpour and Smith (1997) 
defined counselling for their study purposes as “the provision of information on 
medications and related health issues”. The term has also been conceptualised as ”the 
means by which one person helps another to clarify their life situation and to decide 
upon further lines of action”, and its aim is  “to give the client an opportunity to explore, 
discover, and clarify ways of living more resourcefully and towards greater well-being” 
(According to this definition, counselling seeks to enable or empower the patient to 
decide on a particular course of action and see it through (Blenkinsopp et al. 1999). The 
key point is that the counsellor is helping the patient to make their own decision, even if 
that decision varies from that which the counsellor thinks should have been made 
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(Blenkinsopp et al. 1999). This recent definition reflects the transition from a 
paternalistic approach to patient autonomy and decision making.   
 Advice-giving has been referred to as the transfer of information and advice about 
recommended actions from the pharmacist to an individual patient or customer. Ideally, 
advice-giving should be a two-way interactive process, where the person is invited to 
respond and to seek further information should they need it (Blenkinsopp et al. 1999). 
 Some researchers have even questioned if the term counselling can be used to 
describe the information exchange between pharmacists and customers in the context of 
community pharmacy (Raynor 1996, Pilnick 2003). According to these researchers, 
what pharmacists mean by counselling is the imparting of information as part of a one-
way process. In practice, counselling usually involves repeating verbally the 
information on the medicine label and giving instructions for complying with drug 
therapy regimens (Vainio 2004). Therefore, one of these researchers suggests that the 
term concerning advice and explanation about medicines should instead be called 
medicines consultation (Raynor 1996).  
 One of the most comprehensive definitions was constructed by United States 
Pharmacopeia (USP). USP is an independent, science-based, non-profit public health 
organisation which develops and disseminates quality standards and information about 
medicines. According to USP, patient counselling is an approach that focuses on 
enhancing an individual’s problem-solving skills for the purpose of improving or 
maintaining their quality of health and quality of life. The process emphasises that the 
health professional provides and discusses medication information with the appropriate 
person to achieve this goal. The physical, psychological, socio-cultural, emotional, and 
intellectual perspective as well as the health beliefs and values of the individual must be 
respected. The health care professional’s responsibility is to support the person’s efforts 
to develop medication management skills and to move in the direction of self-
responsibility with empathy, sincerity and patience. The nature of the relationship 
between the patient and health care providers is interactive and constitutes a 
collaborative learning process for both parties.  
 As consensus on the concept of what constitutes good patient counselling is lacking, 
it is difficult to compare studies. The precise definition of counselling would also allow 
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the gathering of rigorous evidence of the effectiveness of this service (Raynor 1996). 
Also, a precise definition of the concept would help practitioners to understand and 
internalize the nature and content of good counselling. Furthermore, the understanding 
of a concept has an impact on the behaviour patterns and attitudes. If pharmacy 
practitioners lack the understanding of this key concept, it is difficult to change existing 
performance.  
 
3.2. Research on counselling practice 
 
 Studies assessing counselling performance have revealed that counselling is usually 
based on a monologue model, meaning that the pharmacist gives information to the 
patients without actively engaging them in the process (Pilinick 2002, Rutter et al. 
2004). For example people using antidepressants would need drug information 
customized to their needs (Enäkoski 2002). The level of information is usually brief, 
basic and non-individualized. Moreover, the study methods used have mostly been 
cross-sectional and focused on individual factors affecting counselling practices 
(Laurier and Poston 1992, Willison and Muzzin 1995, Schommer and Wiederholt 1997, 
Aslanpour and Smith 1997, Blom et al. 1998, Pilnick 2003). Research has revealed that 
no single factor can explain counselling practices. However, some factors seem to have 
an impact on counselling practices. First, studies have shown that pharmacists provide 
more counselling to patients with newly dispensed prescriptions than to patients with 
refills (Ascione et al. 1985, Wiederholt et al. 1992, Blom et al. 1993, Sleath 1996, 
Schommer and Wiederholt 1997, Aslanpour and Smith 1997, Vainio et al. 2002). 
Second, patients who ask questions are more likely to be counselled than those who do 
not (Ascione et al. 1985, Schommer and Wiederholt 1997, Vainio et al. 2002). And 
third, the therapeutic class of the drug seems to have an impact to the provision of 
patient counselling (Ascione et al. 1985, Aslanpour and Smith 1997, Vainio et al. 2002). 
Counselling is most likely to be provided for customers with antibiotics and least 
information is given to patients with gynaecologic preparations, cardiovascular 
preparations and oral contraceptives (Ascione et al. 1985, Aslanpour and Smith 1997, 
Vainio et al. 2002). The shift into a preferred customer-oriented negotiation model 
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where pharmacists actively engage customers into interactive and collaborative 
discussion has proved to be challenging.  
 
3.3 The content of the guidelines 
 
 The definitions of patient counselling are reflections of the traditions of the time. This 
is shown by the fact that the recommended topics for patient-pharmacist interaction 
according to patient counselling guidelines vary over time (Table 2). Many professional 
organisations, researchers and scholars in the 1960s and 1970s published guidelines 
regarding what practitioners should talk about during a pharmacist-patient interaction 
(De Young 1996b). Many publications at that time agreed that at a minimum, 
pharmacists should tell patients (1) how to administer the medication, (2) the time of 
medication administration and (3) how to recognize and manage side effects (De Young 
1996b). The development of guidelines continued in the 1980s and 1990s and they 
appeared to be slightly more comprehensive compared to the ones published earlier. 
According to these guidelines pharmacists should tell patients (1) the name of the 
medication and its purpose, (2) the drug dosage form, its route of administration and the 
proper dose and administration schedule, (3) how to identify and manage side-effects, 
(4) how to properly store the medication, (5) any potential drug-drug or drug-food 
interactions, (6) prescription refill information and (7) what patients should do if they 
miss a dose (American Society for Health-System Pharmacists 1997, American Society 
of Consultant Pharmacists 1998). In the United States, the Omnibus Budget 
Reconciliation Act of 1990 (OBRA`90) has required since 1993 that an “offer to 
counsel” must be made. According to OBRA`90 counselling should include e.g., the 
name and description of medication and the duration of therapy (Table 2), Additionally 
pharmacists have been encouraged to use counselling strategies developed for 
pharmacists practising in the Indian Health Service (IHS) (Lee et al. 1998). Pharmacists 
adopting the IHS approach ask patients following questions: 
1. What did your doctor tell you the medicine is for? 
2. How did the doctor tell you to take the medicine? 
3. What did the doctor tell you to expect? 
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4. Just to make sure I didn’t leave anything out, please tell me how you are going 
to take your medicine 
5. What kind of problems have you had with medications in the past? (optional) 
 
 The number and the content of items in the guidelines have remained almost the same 
(Table 2). The guidelines have mostly been recommendations, excluding the OBRA`90 
legislation. However, studies assessing the implementation and actual use of existing 
guidelines in daily practice have not been conducted or published in the peer-reviewed 
literature.   
 
Table 2. Recommended topics for the pharmacist-patient interaction according to some 
selected patient counselling Guidelines (Modified from De Young 1996b). 
 
Prescription drug 
information 
Reeder 
1989 
OBRA` 
1990 
American Society 
of Health-System 
Pharmacists 1997 
American Society 
of Consultant 
Pharmacists 1998 
Medication name, description 
and/or purpose x x x x 
Route, dosage, dosage form, 
and administration schedule x x x x 
Directions for preparation and 
administration  x x x 
Precautions to be observed   x x 
How to identify and manage 
adverse effects x x x x 
Techniques for self-monitoring  x x x 
Proper storage x x x x 
Potential drug-drug, drug-food 
interactions x x x x 
Radiology and laboratory 
procedure issues   x x 
Prescription refill information x x x x 
Action to be taken in the event 
of a missed dose x x x x 
  
 These guidelines reflect the role of the pharmacist and the patient in the interaction, 
and the nature of patient-practitioner relationship, which, according to these guidelines, 
is paternalistic. They also seem like check lists of items that should be told to each 
patient regardless of the individual patient’s needs. The specific counselling items 
included seem to be focused on the drug instead of the patient. Thus, these guidelines do 
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not seem to support patient-centred counselling that is based on a two-way 
communication and negotiation.  
 The literature concerning patient counselling specific guidelines is scarce. In order to 
develop a practice-oriented patient counselling specific instrument, pharmacy 
practitioners should also be involved in the development process.  If the instruments are 
only constructed by academics, it may be hard to implement them in practice. 
Consensus methods provide a good platform to use the expertise of both practitioners 
and academics. 
 
3.4. Situation in Finland 
 
 In Finland, the discussion concerning patient counselling is part of the international 
shift initiated in the 1970s to a greater role for pharmacists (Vainio 2004). In the 1990s 
the community pharmacy facilities were renovated to provide privacy for counselling 
(Table 3). A national survey conducted by the National Agency for Medicines in 1998 
indicated that the most important item in developing pharmacy services was extension 
of patient counselling (Airaksinen et al. 1989, Airaksinen 1996). In the 1990s, the 
professional strategy for community pharmacies provided a framework to develop 
professional pharmacy services that have a special focus on patient counselling. 
However, counselling practices in the 1990s were still drug oriented, and it seemed that 
the principles agreed on in the 1980s still guided the content of counselling (Vainio 
2004).  
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Table 3. Development of drug information in Finland (Source: WHO EuroPharm 
Forum 2005). 
 
Year Action  
1983  Pharmacists´ duty to counsel (Pharmacy Act 4/1928) 
1986 Guidelines on patient information (multidisciplinary) 
1986  The first computerized information database to produce leaflets to consumers (located 
in pharmacies) 
1988 Facilities to assure privacy (Medicines Act 395/1987) 
1993–1996 WHO EuroPharm Forum Questions to Ask About Your Medicines public awareness 
campaign 
1994 Patient Information Leaflets (PILs) through EU regulation 
1997 The professional strategy for community pharmacies (Association of Finnish 
Pharmacies) 
1998 Codes of Ethics for Community Pharmacies (Association of Finnish Pharmacies and 
Finnish Pharmacists’ Association) 
2000–2003 TIPPA Project (operated by the Ministry of Social Affairs and Health, the National 
Agency for Medicines, the Social Insurances Institute, the Association of Finnish 
Pharmacies, the Finnish Pharmacists’ Association, the University of Helsinki and the 
University Kuopio, the Pharmaceutical Learning Centre, and the Kuopio University 
Centre for Training and Development) 
 
 
3.5 Pharmaceutical care 
 
 The philosophy of pharmaceutical care was introduced in 1990 (Hepler and Strand 
1990). The goal of pharmaceutical care is the responsible provision of drug therapy to 
achieve definite outcomes intended to improve a patient’s quality of life. This requires a 
drug therapy system directed toward people’s quality of life. One necessary element of 
such a system is dispensing and patient advice (Hepler 1997). Advice-giving should be 
for the specific purpose of enabling the patient or caregiver to cooperate in his or her 
own care to the fullest possible extent under the circumstances. Patient counselling has 
been one component among many other components in instruments designed to 
measure pharmaceutical care activities (Odenina and Segal 1996, Larson et al. 2002). 
However, these instruments are not patient counselling specific and the lack of patient 
counselling specific instruments is evident. It seems that the concept of patient 
counselling has been underestimated in the instruments that have been developed to 
assess the quality of drug therapies and pharmaceutical care services. This may be due 
to the different payment mechanisms for pharmacy services or different organisation of 
community pharmacies. 
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4  STRATEGIES TO IMPROVE PATIENT COUNSELLING PRACTICES 
 
 Even though the principles of customer-oriented counselling practices have been 
promoted extensively among the profession, research has shown deficiencies in actual 
counselling performance, such as a lack of communication skills, ignoring individual 
patient’s needs and the lack of professional information given to patients (De Young 
1996b, Aslanpour and Smith 1997, Fritsch and Lamp 1997, Morris et al. 1997, Erickson 
et al. 1998, Vainio 2004). This indicates that changing counselling behaviours and 
attitudes is a long-term process. Therefore, multiple and simultaneous approaches are 
required. The diverse variables which affect pharmacist-client consultations should also 
be taken into account in designing interventions to help pharmacists to change their 
counselling performance (Morrow and Hargie 1987, De Young 1996a).   
 The change process can be supported by using different strategies. The profession 
itself can create its own strategy or society can set standards of practice. In this chapter I 
have divided strategies that have been used to change counselling practices into three 
different categories: legislative, professional and educational.  These strategies can be 
considered to have a main focus at different levels: at societal level, at organisational 
level and at individual level (Figure 1).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Different levels and strategies in promoting a change in patient counselling 
practice. 
Pharmacy owner
Individual pharmacists
Pharmacy
AIM:
change in
organisation in 
counselling
practices
Strategies:
legislative
educational
professional
Surrounding society (legislation)       
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4.1 Legislative strategies 
 
 Laws and regulations provide a framework for pharmacists to practice their 
profession. If patient counselling is mandated by law, it creates norms and standards for 
counselling practices. In most European countries, the provision of written drug 
information about prescription medicines and non-prescription medicines is mandated 
by law (Hartikainen 1999). However, oral counselling is seldom mentioned in mandates 
and agreements. Moreover, mandates and other agreements usually do not define the 
minimum content of drug information that should be provided. There are a few 
exceptions: in Finland and in the United States, specific laws mandate the provision of 
oral counselling (Pharmacy Act 58/1983, OBRA`90). 
  In the United States, OBRA´90 requires all pharmacists to provide counselling for 
Medicaid patients and all State Medicaid Agencies (SMAs) to develop and implement 
drug use review (DUR) programs (Pugh 1995).  OBRA ´90 requires that an “offer to 
counsel” must be made, and most states require this to be done by a pharmacist, 
although some states allow a designate or do not address the question. According to 
OBRA´90, counselling should include the name and description of medication, duration 
of therapy, common severe adverse effects, proper storage and refill information.  
 The impact of OBRA´90 has been studied extensively before and after the law took 
effect in the United States (Pugh 1995, Rumore 1995, Barnes et al. 1996, Lyons et al. 
1996, Erickson et al. 1998, Schatz 2003). In general, results indicate that pharmacists 
are spending more time counselling patients after the law was enacted, but fall short of 
complete compliance (Rumore et al. 1995, Erickson et al. 1998, Schatz 2003). Barriers 
for compliance with the law have been assessed. According to studies e.g., lack of time, 
lack of personnel and privacy, and expense constraints have served as barriers (Pugh 
1995, Rumore et al. 1995, Barnes et al. 1996). Some of the pharmacists have also 
indicated a lack of upper management support for patient counselling (Rumore et al. 
1995). Ten years after the law took effect most pharmacies (69%) offered to provide 
prescription counselling, fulfilling the minimum requirement of legislation (Schatz 
2003).  
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 It seems that changes in counselling practices due to legislation are slow (Svarstad et 
al. 2004, Vainio 2004). However, a recent American study revealed that counselling 
practices in different states varied significantly according to the intensity of a state’s 
counselling regulation (Svarstad et al. 2004). More intensive regulations increased the 
likelihood of pharmacist involvement in counselling, provision of risk information, 
assessment of shopper understanding and amount of oral information given. It seems 
that it takes time to teach practitioners and pharmacy students the new counselling 
standards and promote a new role in health care. Other approaches and legislative 
strategies to improve counselling practices are required to promote a change in 
behaviour (Nichol and Michael 1992, Svarstad et al. 2004). Furthermore, laws and 
statutes should also be accompanied by implementation and enforcement systems 
(Nichol and Michael 1992).  
 
4.2 Professional strategies 
 
 Professional organisations can create national strategies to define and promote the 
role of a community pharmacy and community pharmacists in health care. In Finland, 
the pharmacy organisations have been proactive in implementing the requirements of 
the law into practice by developing a professional strategy for community pharmacies 
(The Association of Finnish Pharmacies 1997).  
 In Australia, the pharmacy profession has negotiated agreements with the government 
to incorporate new, remunerated professional services into community pharmacies 
(Roberts et al. 2003). The current agreement is called the Third Community Pharmacy 
Agreement and it is valid until 2005. The Agreement included funding for a Pharmacy 
Development Program, which aimed to promote the enhanced involvement of 
community pharmacy in the pursuit of quality and cost effective service delivery 
(Pharmacy Guild of Australia 2000a). The program incorporated the delivery of Home 
Medicines Review (HMR) and Consumer Medicines Information (CMI). Funding from 
the government was also obtained for a quality assurance and professional practice 
standards program, known as the Quality Care Pharmacy Program (QCPP), the platform 
to which remuneration for the new professional services has been linked (Pharmacy 
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Guild of Australia 2000b). One reason for this approach was that in order for the 
community pharmacy network in Australia to stay viable, new professional services 
were needed (Roberts et al. 2003).  The larger framework for this agreement comes 
from the National Medicines Policy that was launched in 1999. It aims to improve 
positive health outcomes for all Australians through their access to and wise use of 
medicines. The policy has four central objectives: timely access to the medicines that 
Australians need, at a cost individuals and the community can afford; that medicines 
meet appropriate standards of quality, safety and efficacy; quality use of medicines; and 
maintaining a responsible and viable medicines industry.  
 In Australia, the uptake of the QCPP, HMR and CMI has been increasing (Roberts et 
al. 2004). However, the rate of the adoption has not been as fast as was expected, and 
research has been conducted to assess the facilitators for change (Roberts et al. 2003, 
Roberts et al. 2004). These facilitators included e.g., relationship with doctors, 
remuneration, pharmacy layout and communication/teamwork (Roberts et al. 2004).  
 Similar movement among the profession has also occurred in e.g. in England and 
Scotland, where the role of community pharmacy has been developed as part of national 
health care plans (National Health Service 2000, Scottish Executive 2002). However, it 
seems that there is a lack of comprehensive, professional strategies among pharmacy 
organisations worldwide.  
 
4.3 Educational strategies 
 
 Basic education provides a foundation to promote new professional practices and 
behaviours for pharmacy students. Continuing professional development is required to 
fulfil the need of working life pharmacists to gain new knowledge and the skills needed 
in a modern working environment. In Finland, there are still many pharmacists working 
in community pharmacies that have not been instructed in patient counselling, 
communication and pharmacologic skills during their basic education. Therefore, 
continuing education has an important role to play to update their skills and knowledge.  
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4.3.1 Basic education 
 
 The content of basic education should reflect the changes in the pharmacist’s 
professional role and take into account the new role of the patient (Newton 1991, 
Katajavuori 2005). The pharmacy curriculum has traditionally been based on natural 
sciences e.g. chemistry. However, in the United States and in Great Britain, the content 
of the pharmacy curricula has changed towards clinical pharmacy as clinical skills are 
needed in practice (Svarstad 1994, Shaw 2002). Also, patient counselling and 
communication skills courses are essential components in basic and continuing 
education. Furthermore, the teaching methods should reflect the modern philosophy of 
learning (Katajavuori 2005).  At Kuopio University, Faculty of Pharmacy, patient 
counselling has been a part of basic education since the beginning of the training of 
pharmacists in the 1970s (Vainio 2004). However, the first patient counselling course 
that was integrated with communication skills training was organised in 1995. Premises 
for pharmacy students to practice their counselling skills in a pharmacy environment 
were provided in 1987. As part of the Bologna declaration, pharmacy schools are now 
re-evaluating the content of basic education and re-defining the goals for the pharmacy 
curriculum (Hirvonen 2004). According to new goals, graduating pharmacists 
(B.Sc.Pharm) should be able to counsel the patients about prescription and non-
prescription medicines, assess patient symptoms refer them to other health care 
professionals if needed. Also, graduating pharmacists should have the skills for 
continuing professional development (Holm and Hiltunen 2004).  
 
4.3.2 Continuing professional development 
 
 Continuing professional development is one way to promote the new counselling role 
to practising pharmacists. In a changing, increasingly complex profession, and with 
rapid medical and technological advances, the need for continuing professional 
development is evident (Rouse 2004). Several courses have been designed to improve 
pharmacists’ counselling skills (Lee et al. 1998, Vainio et al. 2001, Kansanaho et al. 
2003). A strong direct correlation between the amount of voluntary continuing 
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professional education undertaken and the frequency of counselling has been indicated 
(Holland 1992). Continuing education is also one of the factors influencing the 
provision of pharmaceutical care (Odenina et al. 1995). However, the long-term impact 
on performance is not known, as evaluation has focused on the immediate impact of 
courses. Furthermore, the impact of training seems to deteriorate with time (Morrow 
and Hargie 1987b). In order to change counselling practices, long-term courses are 
needed (Kansanaho et al. 2003). Also, pharmacy owners should be willing to provide 
time and other resources to facilitate the desired change (Kansanaho et al. 2003). 
Pharmacists’ training should be systematic, taking into account the needs of the 
individual pharmacist and the needs of the whole pharmacy. This aspect has not been 
studied extensively even though the problems in implementing new behaviours are 
well-known. One should also take into account factors related to the organiser of 
continuing education, e.g., whether it is organised by the drug industry or by a non-
profit organisation. These aspects may be reflected in the content of continuing 
education and may lead to or reveal conflict(s) of interest.  
 In the Netherlands, a systematic educational intervention was designed to improve 
patient education activities undertaken by pharmacy technicians (Pronk 2002). The 
intervention included course work and on-the-job training. The participants (n=28) 
carried out an inventory of existing practices in their pharmacy and then constructed a 
plan in order to change these. The intervention led to an increase in structured work 
with regard to patient education in participating pharmacies.  
 In the United States, programs aiming to promote and implement pharmaceutical care 
in community pharmacies were run in the 1990s (Blumi et al. 1998, Kassam et al. 
1999). The results of these programs (e.g., Practice Enhancement Program PEP, Project 
ImPACT) showed that pharmacists increased communication with patients and other 
health care professionals and the outcomes of drug therapies improved among targeted 
patient groups (Blumi et al. 2000, Volume et al. 2001). 
  In Australia, a new technique that combined a pseudo customer methodology and 
continuing education was developed to change practice behaviour (De Almeida Neto et 
al. 2001). This training methodology uses the pseudo customer as a change mechanism 
to shape practice behaviour. The new concept starts by workshop training that is 
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followed by pseudo customer visits. After the visits participants are given immediate 
feedback and coaching from an experienced pharmacy educator. This methodology has 
been successfully applied e.g., to pharmacists dealing with non-prescription analgesics 
in Australia and in Switzerland (De Almeida Neto et al. 2001, Sigrist et al. 2002). The 
results indicate that combining training with pseudo customer visits with immediate 
feedback support the learning process and its sustainability.  
 
4.4 Organizational approach 
 
 In the change process, regardless of the strategy chosen, a pharmacy can be viewed as 
an organisation. Thus, organisational theories can be used in development and change 
management projects in the community pharmacy setting. However, only a few studies 
assessing patient counselling have defined variables related to community pharmacy as 
an organisation. The study by Roberts et al. (2003) identified facilitators for the practice 
change process from both a business and a professional perspective. These included: 
remuneration of implementation and/or service; external support or assistance; 
reorganisation of the pharmacy’s structure and function; communication; leadership and 
delegation of tasks. Other studies have also confirmed that the role of management is 
essential in changing existing practices in community pharmacies (Kansanaho et al. 
2003).  
 One of the most used models that describe how to implement change effectively in 
organisations is Rogers’ Diffusion of Innovations theory (Rogers 1995, Rogers 2004). 
This theory has been used in a wide range of disciplines including anthropology, 
education, rural and general sociology and health and mental sociology (Rogers 2004). 
Diffusion is the process trough which an innovation, defined as an idea perceived as 
new, spreads via certain communication channels over time among the members of a 
social system. This theory describes the process of dissemination of new behaviours, 
objects, factors and situations that are of influence to this process. The Diffusion of 
Innovation theory can be used to understand the uptake process of a new professional 
service in community pharmacy (Chen et al. 1999, Pronk 2002, Roberts et al. 2004). It 
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can also explain why people do not react the same way and at the same time to the 
changes suggested.  
 
4.5. Summary 
 
 It is likely that all the three strategies (legislative, professional and educational) are 
needed to promote a change among the profession. It is difficult to evaluate which 
strategy is the most effective. It seems, however, that the profession needs to have a 
strong vision about its future, and concrete actions are needed to meet that vision. 
Furthermore, community pharmacists need supportive actions in the implementation 
process of new professional behaviours and services. In general, it seems that there is a 
need to restructure the whole environment or system in which pharmacists practice to 
achieve sustainable changes in counselling performance (Dickson and Rodowskas 1975, 
Kimberlin et al. 1993, Odenina et al. 1995, Farris and Schopflocher 1999, Roberts et al. 
2003). Also, remuneration of the services may facilitate the change process (Roberts et 
al. 2004).  
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5 EXISTING INSTRUMENTS AND METHODS TO ASSESS PATIENT 
COUNSELLING PERFORMANCES  
 
 Evaluation of existing practices is important as it can direct the development actions 
taken in the pharmacy. Evaluation should be planned and systematic. The evaluation 
requires measures that are relevant to its objectives and sensitive to the anticipated 
outcomes (Smith 2002). Measures are needed as they provide information on current 
practices and therefore, can be used to develop and improve performances. Measures 
should also be applicable to different kind of audits. The audit function can be divided 
into three types: self audit (self-evaluation), peer audit (peer-evaluation) and external 
audit. Self- and peer-audit involve an individual or a group auditing their own 
performance against published standards or personal objectives. External audit occurs 
when persons outside the organisation audit the practice.  
 The common features for an applicable and good measurement are validity and 
reliability (internal consistency). A valid measure is one that taps the construct that it is 
intended to tap (Kidder et al. 1981). Validity is inferred from the manner in which a 
scale is constructed, its ability to predict specific events, or its relationship to measure 
other constructs (DeVellis 1991). There are several other types of validity, e.g. construct 
validity, face validity and criterion validity; however, all types of validity are addressing 
the same issue of the degree of confidence that can be placed on the inferences drawn 
from scale scores (Bowling 1997). Reliability, or internal consistency, is concerned with 
error in measurement. A reliable measure is one that has a small error component and, 
therefore, does not fluctuate randomly from one moment to the next (Kidder et al. 
1981). 
    
5.1 Concept of service quality 
 
 As patient counselling is a professional service, it is important to understand what 
constitutes good service quality. Assessing the quality of patient counselling services 
can be problematic because of the special nature of these services. Three basic 
characteristics of services - intangibility, heterogeneity and inseparability - need to be 
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taken into account in the assessment models (Parasuraman et al 1985). Because services 
are mostly a combination of both performance and products, precise manufacturing 
specifications concerning uniform quality can rarely be set. Services are also 
heterogeneous: their performance often varies from producer to producer, from 
customer to customer. Production and consumption of many services are inseparable. 
Thus, quality occurs during service delivery, usually in an interaction between the client 
and the contact person of the firm.    
 Quality in health care has been defined by Øvretveit (1992) as “fully meeting the 
needs of those who need the service most, at the lowest cost to the organisation, within 
limits and directives set by higher authorities and purchasers”. Furthermore, Øvretveit 
divides health service quality into three dimensions: Client Quality (what clients and 
providers want from service), Professional Quality (the good quality of health care 
professionals and techniques provided) and Management Quality (the most effective 
and productive use of resources).  
 Service quality is a measure of how well the service level delivered matches customer 
expectations. Customers assess service by comparing the service they receive 
(perceptions) with the service they desire (expectations). A company can achieve a 
strong reputation for quality service only when it consistently exceeds customer service 
expectations (Berry et al. 1990). Service quality, as perceived by customers, can be 
defined as the extent of discrepancy between customer expectations or desires and their 
perceptions (Berry et al. 1990).  
 However, customers do not necessarily appreciate the same things as professionals or 
rate services similarly. It is challenging to evaluate service quality because of the 
difficulties involved in delineating and measuring the concept of service quality. One of 
the earliest models was developed by Grönroos (1984) who defined quality as 
functional and technical dimensions. Technical quality refers to what is offered to the 
customer, while functional quality refers to how it is offered. The total quality will be 
expressed as a sum of the functional and technical qualities. Applied to pharmacy 
services, technical quality refers to the quality of the product (drug) dispensed, while 
functional quality refers to the working patterns and technology used in the dispensing 
process (Airaksinen 1996).  
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5.1.2 Instruments to measure service quality 
 
 Factors related to functional quality (how the service is offered) can be understood by 
the well-known theory of Parasuraman et al. (1988). Their definition of service quality 
was based on an explanatory study yielding 10 key categories of service quality 
(accessibility, communication, competence, courtesy, credibility, reliability, 
responsiveness, security, tangibles, and understanding/knowing the customer). 
However, it was revealed that customers can only distinguish between five dimensions 
and factor analysis was conducted to extract these five. The instrument developed was 
named as SERVQUAL (Table 4). The instrument has also been used in community 
pharmacy settings (Hedvall and Paltschik 1991, Airaksinen 1996, Pritchard and Perri 
1997). Hedvall and Paltschik (1991) proposed a four-concept, pharmacy-specific 
solution (Table 4). Professionalism and milieu are the preconditions for the service 
offered. The pharmacists can give added value to their customers by emphasising 
commitment and confidentiality. Airaksinen (1996) assessed customer satisfaction with 
community pharmacy services in Finland, identifying a three factor solution (Table 4).  
Pritchard and Perri (1997) used SERVQUAL as a basis for their own scale that was 
developed to measure the quality of service in a retail pharmacy. The scale measured 
both perceived quality and expected quality and contained 26 items. 
 Community pharmacy specific solutions highlight the professional dimension of the 
services indicating that pharmacists need professional competence to provide good 
quality services to their customers. Also, pharmacists should show empathy to their 
customers. Furthermore, the pharmacy milieu should provide customers privacy and the 
possibility to ask questions.  
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Table 4. Some of the existing service quality instruments and their applicability to 
pharmacy services. 
 
Instrument Dimensions 
SERVQUAL 
(Parasuraman  
et al. 1988) 
Tangibles (the appearance of physical facilities, equipment, personnel and 
communication materials) 
Reliability (the ability to perform the promised service dependably and 
accurately) 
Responsiveness (the willigness to help customers and to provide prompt service) 
Assurance (the knowledge and courtesy of employees and their ability to convey 
trust and confidence)  
Empathy (the provision of caring, individualized attention to customers) 
Hedvall and 
Paltschik (1991) 
Professionalism (having the customer’s best interest at heart and performing the 
duties of the pharmacist promptly and accurately),  
Commitment (making a special effort to serve the customers particularly by 
giving them advice about the product purchased) 
Confidentiality (creating an atmosphere enabling customers to feel that they are 
cared for and enabling them to feel free to discuss problems and ask questions)  
Milieu (the physical premise of the pharmacy) 
Airaksinen 1996 Professional trustworthiness (professional competence and trustworthiness) 
Functional quality (adequacy of time for pharmacist-customer interactions, the 
queuing time and the way customers are treated) 
Privacy (possibility of talking about medicines confidentially in a pharmacy 
setting) 
Pritchard and 
Perri 1997 
Tangibles (the physical facilities, equipment) 
Reliability/assurance (ability to perform the promised service accurately, 
politeness of the employees) 
Responsiveness/Empathy (the caring and individualized attention provided to 
customers, having customers best interest at heart) 
 
 
5.2 Pseudo customer method 
 
 One method that can be used to assess counselling performance is the pseudo 
customer method (Smith 2002). Even though there are other methods to evaluate 
counselling practices e.g., questionnaires, I have focused on a pseudo customer method. 
This is due to the fact that this observational method has proved to be a more reliable 
survey method with respect to the accuracy and consistency of counselling activities 
compared with self-completion questionnaires and diaries (Ortiz et al. 1998).  Pseudo 
customer studies have been used intensively in marketing research, where “mystery 
shopping” (the term used in marketing research) is routinely used to assess the 
performance of the outlets (Wilson 2001). Mystery shopping has its origins in the field 
of cultural anthropology (Wilson 2001). In a mystery shopping study (sometimes also 
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referred to as a shopping survey), the front-line operations of a business are evaluated 
by an anonymous trained observer. Typically, the observer enters the outlet to be 
evaluated posing as an average customer and, immediately after engaging in what 
appears to be a normal customer interaction, completes a detailed report on various 
aspects of the service and shopping environment at the outlet. Mystery shopping is best 
suited when assessing objective characteristics of outlet operations, such as the store 
environment (Finn and Kayandé 1999). 
 Data collected by mystery shoppers can be reported in the form of rating scales, 
checklists, and open-ended responses (Finn and Kayandé 1999). The results are then 
used to compare the performance of particular outlets and their employees, to monitor 
outlet performance over time, and to identify areas where outlets are in most need of 
improvement. Mystery shoppers are increasingly being used to benchmark the 
performance of important competitors or even of outlets in other industry sectors which 
might provide a performance standard (Finn and Kayandé 1999).   
 In health care, the term pseudo customer or pseudo patient is commonly used. Pseudo 
customers can be used overtly (i.e., the simulated patient assumes the role of a patient 
and the person who is being assessed is aware that this is not a genuine patient) or, 
covertly (i.e., where the person being audited are unaware of the simulated patient’s 
identity or purpose). The basic rationale for using covert simulated patients is that a 
testee’s performance alters when the existence of the test is known (Watson et al. 2004).  
 The ethical issues should also be considered when the pseudo customer method is 
used covertly. These studies are a popular and valuable method of obtaining data for 
research on topics of importance to the future of pharmacy, documenting what actually 
goes on in pharmacies rather than what pharmacists report (Smith 2002). However, 
many studies present potential or actual conflicts and compromises between 
safeguarding the rights of study participants to make informed decisions about their 
involvement, while not jeopardising the validity of research. Also, when researching 
sensitive topics there is possibly a need to compromise between achieving study 
objectives and adherence to high ethical standards (Smith 2002).  
 A pseudo customer is an individual trained to present particular scenarios: staff 
whose work is being audited are unaware of the simulated patient’s identity. The visit 
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may take place at anytime within a given time frame. The pseudo customer is trained to 
follow a standard script.  
 The first pseudo customer studies in the context of community pharmacy took place 
at the end of 1960s and at the beginning of the 1970s in the United States (Knapp et al. 
1969, Wertheimer et al. 1973). They showed pharmacists in an unfavourable light 
regarding counselling patients on the use of their drugs. The pseudo customer studies 
continued in the United States and in other countries to assess the quality and content of 
counselling practices in community pharmacies (Rowles et al. 1974, Vanderveen et al. 
1978, Vanderveen and Jirak 1990, Goodburn et al. 1991, Barnett et al. 1992, Krska et al. 
1994, Willison and Muzzin 1995, Lamsam and Kropff 1998, Lyszkiewich et al. 2001, 
Watson et al. 2002, Schatz et al. 2003, Svarstad et al. 2004). The results of the studies 
indicate that counselling practices vary greatly and there is still room for improvement.  
 The method has evolved since its introduction in the field of pharmacy practice 
research when it was mostly used to assess individual pharmacists’ performances. 
Recent studies have used the pseudo customer method as a tool to provide immediate 
feedback to community pharmacists during educational interventions and as a tool to 
change practice behaviour (De Almeida Neto et al. 2001, Sigrist et al. 2002, Berger et 
al. 2005) Also, a virtual pseudo customer has been used to assess the information 
provided through the Internet (Bessel et al. 2003, Kulovaara 2005).  
 
5.2.1 Validity and reliability of the pseudo customer method 
 
 The reliability of any research method can be defined as the extent to which similar 
observations made by different researchers would provide the same results (Wilson 
2001). The literature concerning the validity and reliability of the pseudo customer 
method is scarce. Covert pseudo customers have face validity when the target health 
professional does not know or suspect that they are being confronted by a simulated 
patient. In a study by Watson et al. (2004) only 1% of the pseudo customer visits were 
detected and reported by pharmacy staff. The risk of detection is theoretically greater in 
pharmacies in rural areas where “new faces” are easily spotted.  
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 The use of objective measurement and the careful selection and training of the 
shoppers can increase the reliability of the method (Wilson 2001). Objective 
measurement is clearly possible in verifying that an activity did happen and in situations 
where attributes can be counted. However, judgements on the physical appearance of 
the premises and service personnel as well as the actions of employees in terms of 
politeness, product knowledge, and helpfulness are more subjective. Therefore, this 
subjectivity is minimized by using highly structured response mechanisms such as 
rating scales with descriptive labels. To further improve reliability, the process is 
calibrated by showing mystery shoppers videos or photographs of service environments 
or encounters to illustrate the appropriate rating for a specific type of encounter.  
 Mystery shoppers seem to provide reasonably reliable ratings of the performance of 
retail outlets (Finn and Kayandé 1999). The reliability of mystery shopping data is much 
higher than that of customer surveys, when the data are used for the same problem of 
scaling outlets. There is presumably an advantage in mystery shoppers knowing they are 
going to be evaluating an outlet, whereas customers typically only find out after the fact 
when they are presented with the survey request. There may also be further advantage in 
having individuals who have been trained to be observant providing the assessment 
(Finn and Kayandé 1999). Especially in the community pharmacy setting, a customer 
does not have enough knowledge to assess the professional content of advice given. A 
normal customer might consider friendly service as sufficient whereas pseudo 
customers can assess the actual content of counselling. Krska et al. (1994) concluded 
that determining the patient’s experience of the services does not provide a true 
reflection of the advisory service of the pharmacists and simulations may be more 
accurate.  
 Scoring criteria and the selection of scenarios have a crucial impact on the results of 
pseudo customer studies. Scoring criteria should be developed to take into account the 
needs assessment of individual patients and information tailored to patients’ needs. 
Different scenarios should take into account both non-prescription and prescription 
medicines and the choice of the products available. Also, long-term medication 
scenarios should be developed. Validity of the research findings can be improved by 
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audio-taping the simulated patient visits. Then the tapes can be compared with the filled 
data collection forms (Luck and Peabody 2002). 
 
5.3 Patient counselling specific instruments 
 
 The evaluation of patient counselling performances requires agreement regarding the 
features against which performances should be assessed. “Expert panels” or consensus 
methods such as the Delphi method or the nominal group technique have been used for 
this purpose (Jones and Hunter 1995, Cantrill et al. 1996, Ward et al. 2000). These 
techniques have been applied to establish criteria to assess patient counselling in the 
pharmacy (Ward et al. 2000). Some researchers have also used patient satisfaction 
scales as a basis for their instruments (MacKeigan and Larson 1989). Data on patient 
satisfaction can serve as an indicator of service quality (Pasco 1983). There is a lot of 
material concerning patient satisfaction instruments in the field of health care and 
community pharmacy (Ware and Hays 1988, MacKeigan and Larson 1989, Schommer 
and Wiederholt 1994b). However, as my main focus is patient counselling, I have 
concentrated on the instruments that assess patient counselling practices.  
 Existing patient counselling instruments are shown in Table 5. The Purdue 
Pharmacist Directive Guidance (PPDG) measure can be applied to measure directive 
guidance conducted by pharmaceutical personnel and its impact on the patient’s 
behaviour, and on the outcomes of medical care. It was based on an existing inventory 
of socially supportive behaviours (Gupchup et al. 1996). The PPDG scale is pharmacy 
specific, but it does not include specific items to measure the quality of patient 
counselling. Community pharmacists or patients were not consulted in the development 
process. However, the measure is short and easily administered. It can be used in 
research directed toward identifying variation across pharmacies in levels of directive 
guidance provided to customers. This scale has been further developed to meet the 
needs of hypertensive patients (Sen and Thomas 2000).  
 The criteria developed by Ward et al. (2000) combined consensus techniques with the 
viewpoint of practicing community pharmacists. The criteria were developed by an expert 
panel using the nominal group technique. To ensure feasibility of the criteria, it was sent to six 
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practicing community pharmacists. As a result, the 10 criteria developed by the nominal group 
were reduced to eight criteria (Table 5). However, in reliability testing, predefined levels 
were met excluding three criteria. These excluding criteria were rational content of 
advice, rational product choice and referral to another health professional. The 
instrument demonstrated greater reliability in assessing the process of patient 
counselling (criteria 1,3,4,6) than the appropriateness of advice or action to be taken 
(criteria 5,7,8). Further work is required in order to refine criteria that did not meet the 
predefined standards of reliability. Furthermore, the implementation of the criteria into 
practice should be taken into account.  
 United States Pharmacopeia (USP) started the development of a comprehensive 
medication counselling assessment inventory in 1994. The intent was to construct an 
evaluation tool that contains items having potential application to a variety of 
medication counselling contexts. According to USP, the tool should take into account 
the entire counselling process; interactive communication between the health care 
provider and the patient; the patient’s information needs in self management of the 
treatment; and setting goals for the treatment (Table 5). The exact definition for patient 
counselling was also applied to the development process. The development process of 
the instrument combined the use of an expert panel and the collection of existing 
instruments. The USP Guidelines provide a comprehensive framework to evaluate 
counselling performances (Appendix 1).  
  
  
Table 5. Patient counselling specific instruments. 
Measure Theoretical model Development process Validity/reliability testing Items/dimensions  
The Purdue 
Pharmacist 
Directive Guidance 
(PPDG) (Gupchup 
et al. 1996) 
Inventory of Socially Supportive 
Behaviours (Barrera and Ainley 1983) 
Phone interview  
 
Validity testing: factor analysis 
Reliability testing: Cronbach’s 
alpha 
Two dimensions: Instruction (6 
items) and Feedback and Goal 
Setting (4 items) 
Criteria for 
assessing the 
appropriateness of 
patient counselling 
in community 
pharmacies (Ward 
et al. 2000) 
 Consensus method using 
expert panel (Nominal 
Group Technique) 
 
Face, content and consensual 
validity assessed by sending 
the criteria to community 
pharmacists  
Reliability testing: survey 
among community pharmacists 
who used the instrument to 
assess a sample of vignettes of 
patient counselling scenarios 
8 items: 
1.General communication skills 
2.Information gathered by 
pharmacy staff 
3.How the information is gathered 
4.Issues to be considered before 
giving advice 
5.Rational content of advice given 
6.How advice is given 
7. Rational product choice 
8. Referral 
United States 
Pharmacopeia 
(USP) Medication 
Counselling 
Behaviour 
Guidelines  
Definition of patient counselling: an 
approach that focuses on enhancing 
individual problem-solving skills for 
the purpose of improving or 
maintaining quality of health and 
quality of life. The process emphasises 
that the health professional provides 
and discusses medication information 
with the appropriate person to achieve 
this goal. The physical, psychological, 
socio-cultural, emotional, and 
intellectual perspective as well as the 
health beliefs and values of the 
individual must be respected. 
USP Consumer Interests 
Health Education Panel 
(members representing 
consumers, hospitals, 
schools of pharmacy and 
medicine and drug industry) 
gathered existing 
instruments from health care 
institutions, pharmacy 
schools and practice 
settings, Guidelines 
developed from the existing 
instruments  
Validity and reliability testing 
at this phase: Consensus 
method 
35 items, 4 dimensions 
1. Introduction 
2. Content 
3. Process followed 
4. Conclusion 
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6 AIMS OF THE STUDY 
 
 The overall aim of this study was to develop instruments to measure the quality of 
patient counselling needed in Finnish community pharmacies during the TIPPA project 
(2000–2003). 
 The specific objectives of this study were: 
1. To assess the validity and internal consistency of the USP Medication 
Counselling Behaviour Guidelines. 
2. To assess the perceived usefulness of the USP Medication Counselling 
Behaviour Guidelines among Finnish community pharmacists. 
3. To develop a patient counselling specific quality assurance instrument for self-
audit and external audit of patient counselling practices. 
4. To develop a pseudo customer method to assess the professional content of 
patient counselling practices in Finnish community pharmacies during TIPPA 
project (2000–2003). 
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7  MATERIALS AND METHODS 
 
7.1 The TIPPA Project (2000–2003) 
 
 The TIPPA Project involved all the important parties in the field of pharmacy 
ensuring broad representation and commitment (Table 6). This was significant because 
for the first time, the Ministry of Social Affairs and Health and a major third-party payer 
(Social Insurance Institute) took part in a joint project related to the professional 
development of community pharmacy services. 
 The Project consisted of various planned and co-ordinated activities supporting a 
long-term development process at the pharmacy level (Table 6). The activities took 
place at a national and local level. Emphasis was paid both to basic and to continuing 
professional development. The main operational goal was to implement a new patient 
counselling model based on concordance and two-way communication. This was 
promoted by encouraging pharmacies to develop long-term strategic plans. These long-
term plans included a present state analysis of counselling practices and a step-wise plan 
to achieve strategic goals.  In basic education, patient counselling and communication 
skills courses were modified to better meet the needs of customer-oriented counselling 
practices. In continuing professional development, e.g. a new long-term patient 
counselling course was developed (Kansanaho et al. 2003).  
 Based on previous experience, pharmacists need concrete tools and instrument(s) to 
evaluate and improve their counselling performance (Airaksinen et al. 1998). During the 
project, several practical tools were provided, e.g. a patient counselling and 
communication skills book, electronic, easy-to-use database on prescription medicines, 
a manual on good patient counselling and guidelines for self-medication. 
 The United States Pharmacopeia (USP) Medication Counselling Behaviour 
Guidelines were chosen as the main instrument to promote two-way communication and 
customer-oriented patient counselling. This decision was based on the notion that these 
Guidelines were considered applicable in a community pharmacy setting and they were 
regarded as comprehensive. Furthermore, there were not many alternatives available 
(see chapter 5). The Guidelines were translated to Finnish (Hakkarainen and Airaksinen 
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2001). The Guidelines were first used in the education of pharmacy students to teach the 
principles of patient counselling. In continuing education, the Guidelines were 
systematically used to promote self-evaluation of counselling practices. They were also 
integrated into patient counselling and communication skills study books and a quality 
manual (TIPPA Final Report 2005). Also, in the beginning of the TIPPA project the 
Finnish Pharmacists’ Association sent the Guidelines to all pharmacists working in 
community pharmacies.  
 The progress of patient counselling practices was evaluated during the project by 
using a pseudo customer method. Also several other research projects were conducted 
during the project to provide evidence of the changes that occurred in patient 
counselling practices and actions taken in community pharmacies (Varunki 2003, 
Kansanaho et al. 2004, TIPPA Final Report 2005). In addition, the implementation of 
the tools provided was assessed during the project (Varunki 2003, Kansanaho et al. 
2005, Saario 2005).  
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Table 6. Outline of the TIPPA Project. 
 
TIPPA (2000–2003) 
TIPPA was a 4-year national joint project to promote the implementation of a professional strategy by 
enhancing patient counselling in Finnish community pharmacies. 
The Project was operated by the Ministry of Social Affairs and Health, the National Agency for 
Medicines, the Social Insurances Institute, the Association of Finnish Pharmacies, the Finnish 
Pharmacists’ Association, the University of Helsinki and the University Kuopio, the Pharmaceutical 
Learning Centre, and the Kuopio University Centre for Training and Development. 
Drug policy goals 
TIPPA aimed at promoting the rational use of medicines; decreasing the negative effects of inappropriate 
use of medicines, including self-medication; and decreasing costs by enhanced patient counselling. 
Operational goals 
Phase 1 (2000–2001): Introducing practitioners to new counselling behaviours (raising awareness), 
developing resources and tools specifically for patient counselling (e.g. easy-to-use electronic prescription 
drugs database, handbooks on self-medication, manual on quality assurance of counselling practices, 
handbook on patient counselling and communication). 
Phase 2 (2001–2002): Facilitating self-assessment of counselling practices and processing long-term 
development plans, training of TIPPA tutors 
Phase 3 (2002–2003): Implementing and promoting the use of patient-counselling resources; assessment 
of the implementation of TIPPA resources and tools. 
Phase 4 (2003): Evaluation and reporting. Constructing a new action plan based on the evaluation 
 
7.2 Study design 
 
 The study commenced with an assessment of the validity and internal consistency of 
the USP Medication Counselling Behaviour Guidelines in co-operation with United 
States Pharmacopeia (I). Their usefulness in improving patient counselling practices in 
Finnish community pharmacies was assessed two and half years after the TIPPA project 
had started (II). During the TIPPA Project, the need for a more comprehensive quality 
assurance instrument became evident. Ten experienced community pharmacists, with 
Masters degrees in pharmacy (M.Sc.Pharm), were trained to act as external auditors of 
patient counselling practices (TIPPA tutors), and a patient counselling specific 
instrument was needed for the process. The instrument was constructed during the 
training of the TIPPA tutors in 2001 (III). As the aim of the TIPPA project was to 
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enhance patient counselling in community pharmacies, a pseudo customer method was 
developed to assess the progress that occurred in counselling practices during the 
project in 2000−2003 (IV).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Outline of the studies (I-IV) conducted during 1999–2003. 
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Table 7. Methods used in original publications (I-IV). 
STUDY METHOD CRITERIA STATISTICS 
 
I 
 
Validity and reliability assessment 
• 36 pharmacists rated the six  selected 
videotaped counselling sessions 
(n=216) 
 
USP medication counselling behaviour  guidelines 
(Appendix 1) 
• 35 items 
• 4 subscales: Introduction, Content, Process 
  and Conclusion  
 
 
Correlation analysis (Pearson coefficient) 
Factor analysis with varimax rotation 
Internal consistency with Cronbach’s alpha 
 
II 
 
Survey 
• postal questionnaire 
• a sample of every fifth 
  pharmacists on the register (n=734) 
• response rate 51% (n=374) 
 
How well the respondents knew the Guidelines 
• the applicability of the Guidelines in patient 
counselling and in self-evaluation 
• their usefulness as an instrument to learn the 
principles of patient counselling in different 
settings 
 
 
Descriptive statistics (means, standard deviations,  
Cross-tabs method, Chi-square tests) 
 
III 
 
Modified Delphi 
• 2 expert groups (n=20) 
• Delphi questionnaire (n=35) 
• response rate 74% (n=26) 
    
5-point Likert scale 
• the item should be retained: ≥ 75% of 
participants scored the item ≥ 4 
• the item should be excluded: ≥ 75% of 
participants scored the item ≤ 2 
• no consensus: item which failed to meet either 
of the other criteria. 
 
 
 
IV 
 
Pseudo customer study (2000–2003) 
• 60 community pharmacies 
• baseline and 3 annual follow-ups  
• 4 scenarios (n=960) 
 
Scoring criteria divided into 2 subscales: Needs 
assessment and Instructions to Use (Appendix 2) 
Based on USP Guidelines 
Maximum score 5–8 according to the scenario 
 
 
Total scores and scores for subscales 
Descriptive statistics (means, standard deviations) 
Non-parametric Friedman test  
  
50 
51 
 
7.3 Validation of the USP Medication Counselling Behaviour Guidelines (I) 
 
 This study was conducted in cooperation with United States Pharmacopeia (USP). 
Thirty-six pharmacists from Maryland and Washington, DC were recruited to evaluate 
six selected videotaped vignettes by using the Medication Counselling Behaviour 
Guidelines (n=216). Videotaped vignettes were provided by the national Patient 
Counselling Competition in the USA. The event has been organized annually by the 
USP in co-operation with the American Pharmaceutical Association. The competition 
provided an opportunity for pharmacy students to practice their counselling skills. The 
scenarios used simulated real counselling sessions on prescription medications in the 
community pharmacy. The sessions were videotaped and evaluated. After evaluation, 
the students were given feedback on their counselling skills. Six videotaped sessions, 
involving four female and two male pharmacists, were selected to represent different 
types of scenarios. The selected videotapes were among the tapes of the finalists of the 
Patient Counselling Competition in 1995–1997. The tapes were obtained for research 
purposes, consequently they are not freely available. 
 All the 35 items of the Medication Counselling Behaviour Guidelines were subjected 
to basic correlation analysis with Pearson coefficient before conducting factor analysis.  
A limit of 0.3 was set to the correlations; items that did not have a correlation of 0.3 
with any item were excluded from the scale.  This was done because high inter-
correlation between the items facilitates the determination of patterns of constructs in 
the data. 
 To determine the construct validity of the scale, all the items having correlations 
above 0.3 with at least one variable were subjected to factor analysis with the extraction 
method of principal component analysis.  Principal component analysis was chosen as 
the analysis method as it applies to determining the components rather than explaining 
the variance between the original variables and new components (DeVellis 1991). The 
rotation method was an orthogonal varimax with Kaiser normalization. In factor 
analysis, reference axes are rotated to increase interpretability of factors. Depending on 
angular separation of reference axes, the rotation can be either orthogonal or oblique. 
 Internal consistency was assessed by calculating Cronbach’s alpha values.  Alpha 
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values above 0.7 were considered as good (Nunnally and Bernstein 1994).  The analysis 
was conducted for both the original scale and the new scale which was constructed from 
the original using principal component analysis.   
 
7.4 Finnish community pharmacists’ perceptions of the usefulness of the USP 
Guidelines (II)  
 
 Staff pharmacists from community pharmacies were selected as a target group for this 
study as they are the personnel group responsible for customer service in Finnish 
community pharmacies.  A sample of every fifth pharmacist on the register was 
produced alphabetically from the professional membership lists of those pharmacists 
with a Bachelor’s Degree (the Finnish Pharmacists’ Association) and those with a 
Master’s Degree (the Finnish Pharmacists’ Association and the Society of Pharmacists).  
A total sample of 734 registered pharmacists was surveyed. The initial mailing included 
a letter of transmittal guaranteeing anonymity, the questionnaire and return envelope.  
The letters were mailed out on university stationery. Two reminder letters were sent out, 
the first in August and the second in September in 2002. 
 A total of 376 responses were received (response rate 51%).  The characteristics of 
the respondents were similar to those of the target population (II, Table 1). The mean 
age of the respondents was 35 years. 
 The questionnaire included both structured and open-ended questions concerning the 
usefulness of the Guidelines, altogether 12 questions (Appendix 3). The respondents 
were asked how well they knew the Guidelines, where they had learnt about the 
Guidelines, the applicability of the Guidelines in patient counselling and in self-
evaluation, and their usefulness as an instrument to learn the principles of patient 
counselling in different settings. The respondents were also asked to describe the ways 
of using the Guidelines in practice and to provide suggestions for improvement and 
reasons for not using the Guidelines.   
 Descriptive statistics on the sample characteristics and questionnaire items were 
computed, including means, standard deviations (SDs) and frequency distributions. 
Cross-tabulation methods and the Chi-square test were used to assess the dependency 
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between different variables. P-values less than 0.05 were considered to be significant. 
The open-ended questions were analyzed based on their thematic content (Pietilä 1976). 
The data were analysed using the SPSS 10.1 statistical software. 
 
7.5 Development of the patient counselling specific quality assurance instrument 
(III) 
 
 The method used in this study was a modified Delphi method. Delphi can be 
characterized as a method for structuring a group communication process so that the 
process is effective in allowing a group of individuals, as a whole, to deal with a 
complex problem (Linstone and Turoff 1975). Experts are invited to give their opinions 
on the specific matter by participating in several questionnaire rounds, which are 
repeated until an acceptable degree of consensus is obtained.  The development of 
consensus guidelines or standards where research based evidence is absent or 
inconclusive are typical applications of the method.  
 The first phase is usually conducted by the researcher, who selects the material that is 
provided to the experts; commonly one panel is used, with some exceptions (Duffield 
1993). However, in our study we chose an approach based on the practical expertise of 
the panel members, and the Delphi method was considered feasible for this purpose.  
 Two expert panels were established: one with ten experienced practitioners being 
trained to become external auditors of patient counselling practice in the national TIPPA 
Project (Panel 1), and the other consisting of the members of the executive committee of 
the Project (n=10) with academic and professional expertise (Panel 2).  Panel 1 made 
the first draft with factors related to the quality of patient counselling based on a 
brainstorming session. The structure and related measures of the tool were reviewed by 
the second panel and piloted by the first panel in ten pharmacies.  
 Final consensus was assessed by a Delphi questionnaire sent to the members of 
Panels 1 and 2, the employers of Panel 1 (n=5) and to the members of the executive 
board (n=10) of the TIPPA project, altogether to 35 people (response rate 74%). The 
participants were asked to rate the applicability of each quality dimension and related 
indicators, the general structure of the instrument, and items related to the vision and 
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strategy (n=28) on a 5-point Likert scale ranging from 1 (= fully disagree) to 5 (= fully 
agree).  
 The respondents were also asked to comment if any factors that influence patient 
counselling quality were missing from the instrument. The following definitions of 
consensus were established before data analysis: consensus that the items should be 
retained: ≥ 75% of participants scored the item ≥ 4; consensus that the item should be 
excluded: ≥ 75% of participants scored the item ≤ 2; no consensus: item which failed to 
meet either of the other criteria. The percentages were calculated using the SPSS 10.1 
statistical software. 
 
7.6 Development of the pseudo customer method to assess patient counselling 
practices among Finnish community pharmacists (IV) 
 
 The data for this study were collected by using a pseudo customer method. The 
pseudo customer visits were conducted in a purposive sample of 60 community 
pharmacies out of the total number of about 600 pharmacies, having different 
geographic location, size in terms of annual prescription volume and service design (IV, 
Table 1).  
 A scoring system was developed to analyze the interactions between the pseudo 
customer and the pharmacist.  The scoring criteria were based on the United States 
Pharmacopeia (USP) Medication Counselling Behaviour Guidelines. Total scores and 
scores for two subscales “Needs Assessment” and “Instructions to Use” were calculated  
for each visit (Appendix 2). The “Needs Assessment” subscale included items related to 
clinical assessment, such as who is the medicine for and what are the patient’s     
symptoms. The “Instructions to Use” subscale included information on how to use the 
medicine, such as the dosage and the duration of the treatment. Both of these subscales 
were customized according to each individual scenario. One point was allocated for 
each item, yielding a maximum score between 5−8 depending on the scenario 
(Appendix 2).  
 Four different scenarios (Appendix 2) were used in each pharmacy, yielding 240 
visits per each time point measured (baseline in December 1999 – March 2000, and 
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three follow-ups in December 2000-January 2001; November 2001-December 2001; 
and January 2003-February 2003, respectively).  In total, 960 interactions were 
analysed, 240 interactions per each scenario.   
 The scenarios were selected to represent different types of common requests in 
pharmacies. The three self-medication scenarios were based on sales statistics, 
representing some of the typical symptoms for self-medication (National Agency for 
Medicines and Social Insurance Institution 1999). Scenario four for a prescription 
medication consisted of two different approaches with a new (baseline and the second 
follow up) and a repeat prescription (the first and the third follow up).  
 The visits were conducted by a research institute that specialized in pseudo customer 
studies. The research institute trained the pseudo-customers according to instructions by 
the TIPPA Executive Committee, and the institute independently selected the study 
pharmacies.  
 Pseudo customers made notes immediately after each visit using a structured form 
customized to each scenario. During the baseline, structured data forms were the only 
method to record the interaction. The method was further developed in co-operation 
with the University of Sydney, Australia. Based on their experience, some of the 
interactions were also audio-taped during the three follow-up studies (n=37). These 
tapes were transcribed verbatim.  
 In addition to calculating total scores and scores for subscales for each visit, 
descriptive statistics were computed, including means, standard deviations (SDs) and 
frequency distributions by using SPSS 10.1 statistical software. The total scores for 
three self-medication scenarios were summarized in each time point measured. 
 All Finnish community pharmacies received an information leaflet about the pseudo 
customer study by the Association of Finnish Pharmacies four weeks before the baseline 
assessment. Pharmacies could decline to participate by informing the Association of 
Finnish Pharmacies, and seven did so. Pharmacies were blinded for the scenarios, 
pseudo customers and time of visits. No reminders were sent during the project. Those 
community pharmacies that took part of the project, received the information on their 
scorings only after the TIPPA project had finished.  
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8 RESULTS 
 
8.1 Validity and internal consistency of the USP Guidelines (I) 
 
 The study showed that the USP Medication Counselling Behaviour Guidelines are a 
flexible tool that can be used and modified in several ways without threatening its 
validity and reliability. Statistical analysis indicated good construct validity and internal 
consistency of the original Guidelines. Cronbach's alpha for the whole original scale 
was 0.91 and for the four original subscales Introduction 0.70, Content 0.86, Process 
0.86, and Conclusion 0.80, respectively.   
 Further statistical analysis with the scale using factor analysis yielded three strong 
components explaining 57% of the variance that were interpreted as “Communication” 
(17 items), “Management of the Treatment” (12 items) and “Warnings and Precautions” 
(6 items) based on their content.  
 However, there were some negative high loadings on the components. Thus, it was 
decided to conduct one more principal component analysis using Oblimin rotation with 
Kaiser Normalization as a rotation method (Nunnally and Bernstein 1994). The four-
component solution explained 76% of the variance, and did not have any strong 
negative loadings (Table 7). These four components were named as “Needs 
Assessment” (9 items), “Precautions and Warnings” (8 items), “Management of the 
Treatment” (13 items), and “Communication” (5 items).  Based on these results, a new 
scale was constructed (Table 7). 
 This 4-component solution showed also high internal consistency with a Cronbach’s 
alpha 0.85 for the whole scale, and 0.87, 0.88, 0.95, and 0.75 for the new subscales, 
respectively. 
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Table 7. The new scale based on the results of the four-component solution with 
rotation method of Oblimin with Kaiser Normalization. 
 
Component Loading 
Component 1. Needs assessment (Cronbach’s alpha 0.87)  
1.  Obtains pertinent initial drug related information  
 (e.g. allergies, other medications, age, etc)  1.010 
2.  Responds with understanding/empathic responses  .987 
3.  Reviews patient record prior to counselling  .908 
4.  Explains the purpose of the counselling session  .897 
5.  Presents facts and concepts in a logical order  .849 
6.  Uses appropriate counselling aids to support counselling  .837 
7.  Assesses any actual and/or potential concerns or problems of importance to the 
 patient  .774 
8.  Determines if the patient has any other medical conditions which could 
 influence the effects of this drug or influence the likelihood of an adverse 
 reaction  
.563 
9.  Conducts appropriate counselling introduction by identifying self and the patient 
 or patient`s agent 
 
.545 
Component 2. Precautions and Warnings (Cronbach’s alpha 0.88) 
10.  Explores with the patient potential problems in taking the medication as 
 prescribed (e.g. cost, access, etc.)  .886 
11. Discusses potential (significant) side effects  .874 
12. Warns patient about taking other medications, including OTCs, 
 herbals/botanicals and alcohol, which could inhibit or interact with the 
 prescribed medication  
.825 
13. Discusses significant drug-drug, drug-food, and drug-disease interactions .817 
14. Discusses precautions (activities to avoid, etc.)  .793 
15. Explains in precise terms what to do if the patient misses a dose  .682 
16. Discusses how to prevent or manage the side effects of the drug if they do occur  .577 
17. Helps patient generate solutions to potential problems  
 .400 
Component 3. Management of the Treatment (Cronbach’s alpha 0.95) 
18. Discusses storage recommendations, ancillary instructions  
 (e.g. shake well, refrigerate, etc.)  .953 
19. Explains how long it will take for the drug to show an effect  .920 
20. Tells patient when he/she is due back for a refill  .917 
21. Summarizes by acknowledging and/or emphasizing key points of information  .888 
22. Emphasizes the benefits of completing the medication as prescribed  .852 
23. Helps patient to plan follow-up and next steps  .851 
24. Provides an opportunity for final concerns or questions  .841 
25. Verifies patient’s understanding via feedback  .730 
26. Maintains control and direction of the counselling session  .677 
27. Assists the patient in developing a plan to incorporate the medication regimen 
  into his/her daily routine  .653 
28. Uses open-ended questions  .593 
29. Explains the dosage regimen, including scheduling and duration of therapy when 
  appropriate  .522 
30. Probes for additional information  
 .428 
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Table 7. continued  
 
Component 4. Communication (Cronbach’s alpha 0.75) 
31. Uses language the patient is likely to understand  .868 
32. Provides accurate information  .593 
33. Discusses the name and indication of the medication  .553 
34. Displays effective nonverbal behaviors: 
 a. Appropriate eye contact 
 b. Voice is audible; tone and pace are good 
 c. Body language, postures and gestures support the spoken message 
 d. Distance between the health care professional and patient is  appropriate 
.506 
35. Assesses the patient`s understanding of the reason(s) for the therapy .396 
 
 
 
8.2 Perceived usefulness of the USP Guidelines among Finnish community 
pharmacists (II) 
 
 More than one quarter (27%) of the respondents was aware of the Guidelines. The 
Guidelines were made known to the respondents mostly by the patient counselling skills 
study book (41% of those knowing the Guidelines), continuing education (37%), and by 
in-house training (28 %). Over 60% (n=68) of those who knew the Guidelines regarded 
them as a good or very good instrument for learning the principles of patient 
counselling. The applicability of the Guidelines as an instrument for self-evaluation of 
performance in different settings was considered less useful, with approximately 50% 
regarding them as a good or very good instrument in this respect.   
 The themes emerging from the open-ended question “How have you used the USP 
Guidelines?” were related to customizing patient counselling and using the Guidelines 
in in-house training. Many examples reflected the fact that respondents used the 
Guidelines in processing patient counselling into different components (introduction, 
content, process and conclusion). They also utilised them in tutoring pharmacy students 
during their practical training period, indicating that they were an instrument for 
teaching the principles of patient counselling. 
 The themes emerging from the second open-ended question, “How would you 
improve the applicability of the Guidelines in patient counselling in practice?”, were 
related to the fact that they should be simplified and made shorter. Respondents thought 
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that the principles should be explained and practical examples should be given when 
training pharmacists to use the Guidelines. Suggestions for improving the applicability 
of the Guidelines in self-evaluation included giving practical examples and using 
exercises. 
 The themes emerging from the third open-ended question, “Why are the Guidelines 
not applicable in practice?”, were related to the length and comprehensiveness of the 
Guidelines. The reasons why the Guidelines were not applicable included the following: 
the Guidelines are too theoretical, too complex and too detailed. Lack of time for 
counselling, the impracticality of the Guidelines, and the attitude of the employers in the 
pharmacy were also mentioned as barriers to the use of the Guidelines.   
 
8.3 Patient counselling specific quality assurance instrument (III) 
 
     The brainstorming session by Panel 1 yielded 7 factors related to the quality of 
patient counselling. Panel 1 agreed to choose three of these as the main quality 
dimensions, and place the remaining factors under these dimensions. These dimensions 
were named on the basis of their content as follows: Customer, Personnel, and 
Technical Resources.  
  As the structure was similar to the Balanced Scorecard, Panel 2 decided to use that as 
a model for the instrument. The Balanced Scorecard is a quality management system 
that enables an organisation to clarify its vision and strategy and translate them into 
action (Kaplan and Norton 1996). The indicators of the original Balanced Scorecard 
view organizational performance from four perspectives: Financial, Customer, Internal 
Business Process, and Learning and Growth.  However, its structure is flexible to permit 
local modifications, including the number of quality dimensions.  
  Vision and strategy of the pharmacy in patient counselling became the core element 
of the instrument developed (Figure 3). The financial dimension was left out of the 
instrument as it was considered to be measured by general quality assurance systems in 
pharmacies. Three patient counselling specific quality dimensions that need to be taken 
into account in strategic planning and systematic long-term development processes are 
as follows: 
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 Customer: The Customer dimension consists of indicators that enable one to 
understand the customers’ specific information and communication needs. These 
indicators include systematic assessment of customers’ drug use patterns and disease 
profiles, and customer feedback using traditional customer satisfaction questionnaires or 
pseudo-customer studies.  
 Process: The goal of the Process dimension is to integrate patient counselling into the 
process of dispensing prescription and non-prescription medicines. Drug information 
sources, both electronic and manual, should be accessible during dispensing, and the 
personnel should be able to use them. The pharmacy premises should permit private 
patient consultations. In the pharmacy, pharmacists should establish guidelines 
concerning patient counselling practices. Such guidelines should also be arranged with 
other local heath care professionals.  
 Learning and innovations: The Learning and Innovations dimension relates to the 
competency of the pharmacy personnel: they should have adequate skills and 
knowledge to meet customers’ needs. The principles of customer-oriented counselling 
should be known and internalized by the pharmacists.  This can be supported by 
constructing systematic in-house and continuing education plans for individual 
pharmacists. Self-evaluation and peer-evaluation of performance can be used to 
evaluate patient counselling practices. In regular development discussions with the 
pharmacy personnel, particular attention can be paid to patient counselling skills and 
setting goals for personal development.  
 
8.3.1 Delphi questionnaire round 
 The level of agreement of the individual indicators (n=28) varied from 69 % to 100% 
(III, Table 2). Eighteen of the 28 indicators (64%) reached a consensus rate higher than 
90%. Only one indicator (concerning the use of peer audit as an instrument to assess 
performance) did not meet the criteria for approval reaching the agreement level of 
69%. Only one questionnaire round was needed as the respondents had a high consensus 
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about the indicators and they did not recommend any additional items for the 
instrument. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Quality dimensions with related indicators. 
 
8.4 Progress in patient counselling practices during the TIPPA project (IV) 
 
 The results of the pseudo customer study showed that the amount and quality of 
counselling varied greatly between the different scenarios used. The proportion of 
pseudo customers receiving at least one piece of information included in the scoring 
criteria increased from 44% at the baseline in 2000 to 61% at the third follow-up in 
Customer
• Structure of customers 
(with the most common diseases)
• Most common drug therapies 
among customers
• Systematic collection of 
customer feedback
• Pseudo customer studies
Vision and strategy
of the pharmacy 
in patient counselling
Learning and Innovations
• Principles of customer-oriented 
patient counselling
• Continuing professional development
• Sharing successful patient 
counselling cases with colleagues
• Self-evaluation of performance
• Peer-evaluation of performance
• Development discussions concerning 
patient counselling
Process
• Technical skills in processing 
prescriptions
• Availability and access to information 
sources (manual and electronic)
• Facilities (e.g. privacy, access to 
a pharmacist)
• Integration of patient counselling
into the dispensing process
• Guidelines on patient counselling
in the pharmacy
• Integration with local health care
62 
 
2003. Two out of the four scenarios showed a statistically significant difference 
(p<0.05) between the baseline and the third follow-up. This concerned both total scores 
and scores for both subscales “Needs Assessment” and “Instructions to Use” in scenario 
1 (IV, Figure 1). For scenario four concerning a prescription medicine, total scores, and 
the subscale “Instructions to Use” showed a statistically significant increase in scores 
for a new (p=0.004) and a repeat prescription (p=0.03) (IV, Figure 2).  
 The amount of information provided to the pseudo customers showed an increase, 
measured as scores obtained per visit. This was the case with three out of the four 
scenarios used. The only exception was the direct product request (Scenario 3) where 
the proportion of pseudo customers receiving information remained relatively stable 
during each time point measured. The proportion of pseudo customers receiving no 
information included in the scoring criteria decreased in two out of the four scenarios 
during the project (IV, Table 3).  
 Statistical analysis of the aggregated total scores of the three self medication 
scenarios between the baseline and the third measurement revealed no significant 
differences, p=0,439 (the baseline: mean 3.77, SD+2.36; the first follow up: mean 3.42, 
SD+2.61; the second follow up: mean 3.77, SD+2.52; and  the third follow up: mean 
3.82, SD +3.03). 
 
8.5 Summary of the results 
 
 In this study, patient counselling specific instruments were developed to assess 
counselling practices in community pharmacies. The instruments can be used in 
evaluating counselling practices at different levels. At the organisational level, the 
patient counselling specific quality assurance tool can be used in conducting a present 
state analysis of counselling performance and then constructing a long-term 
development plan. The quality assurance instrument can also be used in an external 
audit of counselling practices. The pseudo customer method can be applied at the 
organisational and national level to assess counselling performances. Individual 
pharmacists can use the USP Guidelines to assess their own performance. USP 
Guidelines are also suitable for peer-evaluation.   
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Figure 4. Developed instruments and their use at different levels. 
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9  DISCUSSION 
 
9.1 Context of this study 
 
 The data for this study was mostly collected during 2000−2003 when the national 
patient counselling development project TIPPA was run. TIPPA was the leading 
professional project among the pharmacy profession in Finland since its beginning in 
2000. It was also a quality improvement project targeted at community pharmacies. 
Research has revealed some preconditions for successful quality improvement projects 
such as senior management commitment, sufficient resources, careful programme 
management and practical and relevant training which personnel can use immediately 
(Øvretveit and Gustafson 2002). In the action plan for TIPPA, these aspects were taken 
into account by e.g., involving the pharmacy owners to the project, providing 
pharmacists with concrete tools and instrument to enhance counselling and by providing 
continuing education. The TIPPA project was a unique intervention that mobilised 
resources and multidisciplinary actions over a period of years to change counselling 
practice.  Implementing change is usually not a single action but involves a well 
planned stepwise process, including a combination of interventions, linked to specific 
obstacles to change (Haines and Jones 1994, Armstrong et al. 1996, Grol 1997, Helin-
Salmivaara et al. 2003).   
 In order to promote a change in counselling performance, community pharmacists 
needed a concept of what constitutes good counselling. The literature review revealed 
that there is a lack of instruments to assess and evaluate counselling practices. The USP 
Guidelines were considered to be applicable, even though their comprehensiveness and 
length were predicted to result in some resistance among the practitioners. In addition, 
they were developed in the United States, where the professional context and culture are 
different. However, the decision was based on the fact that the Guidelines provide a 
comprehensive framework to gain an understanding of customer-oriented counselling 
practices and two-way communication. Furthermore, they are applicable both to self-
evaluation and to peer-evaluation.  
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 During the project, the change process at the organisational level was facilitated by 
training external auditors of counselling practices. Their mission at the pharmacies was 
to help the pharmacy owner and pharmacists to conduct a present state analysis of 
counselling practices and then to construct a long-term development plan. For this 
purpose, a patient counselling specific instrument was developed by use of a modified 
Delphi method. This method was chosen as consensus methods are applicable when the 
aim is to develop guidelines or standards where research-based evidence is absent or 
inconclusive (Cantrill et al. 1996). The use of a modified Delphi method provided the 
possibility to use two expert panels and to combine the expertise of practising 
pharmacists with the expertise of pharmacists working in academic and professional 
organizations. 
 The evaluation of the actions taken in pharmacies, and the implementation of the 
instruments provided were an essential part of the programme. The information 
provided by the evaluation was crucial as subsequent activities taken during the project 
were based on this evaluation process: the project aimed at reflectivity and flexibility. In 
order to assess counselling practices and the changes that occurred in them, a pseudo 
customer method was developed. The scoring criteria were based on the USP 
Guidelines and emphasised the professional content of counselling. However, it is 
noteworthy that the use of different scoring criteria concerning e.g., technical aspects of 
medicines (such as the drug formula or price), would likely have lead to different 
results. Nevertheless, a similar method may be adopted in the future to develop different 
scoring systems. The decision was based on the notion that we wanted to gain 
information about professionally oriented counselling practices.  
 
9.1.1. Activities after the TIPPA project 
 
 Professional community pharmacy services are undergoing further development as 
part of the new action plan following the TIPPA project. Key stakeholders in the field of 
pharmacy have found nationally co-ordinated, long-term activities necessary to promote 
health policy goals through professional community pharmacy services. It was agreed 
that there is a need to continue this co-operation in the form of national co-ordination of 
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activities with a special focus on integrating community pharmacists into local 
multidisciplinary teams. The goals of the TIPPA project and the new action plan are in 
line with the professional strategy for community pharmacies. The professional 
community pharmacy strategy is also supported by the National Pharmaceutical Drug 
Policy for 2010 established by the Ministry of Social Affairs and Health in 2003. 
According to this policy statement, good medical treatment requires that information 
about medicines and their appropriate use be given by pharmacy staff. 
 
9.2 Key findings 
 
9.2.1 Patient counselling specific instruments 
  
 The results of this study revealed that the quality of patient counselling is determined 
by several dimensions. Customers’ needs, professional competence of the personnel and 
the dispensing process should be taken into account in the development process of 
counselling practices. Similar dimensions have been found also in previous studies 
assessing service quality in the context of health care (Hedvall and Paltschik 1991, 
Øvretveit 1992, Airaksinen 1996, Pritchard and Perri 1997). Our results also show the 
importance of management in improving quality. Although the quality of pharmacy 
services depends upon individual factors, such as having appropriate facilities and 
competent personnel, it is the organisation of these resources and supporting 
information systems that really enable effective quality management. In order to 
implement high quality patient counselling, current practices need to be evaluated from 
a wider perspective than the customer-pharmacist interaction.  
 The role of management in bringing about change is essential (Kansanaho et al. 2003, 
Roberts et al. 2003). The vision and strategy of the pharmacy in patient counselling 
formed the core of the developed instrument, indicating the important role of the 
pharmacy owner in the development process. The evaluation process in the pharmacy 
should be managed and lead by the pharmacy owner. The decision of which measures to 
use is strategic in nature: it is said that people do what is being measured. If the 
pharmacy owner is not involved with the development project, it is difficult to 
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implement new practices (Kansanaho et al. 2003, Varunki 2003). The organisational 
culture in the pharmacies should be studied in the development projects. However, there 
is limited published data in this area, with most studies that assess counselling practices 
focusing on the individual patient- or pharmacist-related factors (Laurier and Poston 
1992, Willison and Muzzin 1995, Schommer and Wiederholt 1997, Aslanpour and 
Smith 1997, Blom et al. 1998, Pilnick 2003). 
   Evaluation of counselling performance in community pharmacies is not very common 
among community pharmacists in Finland. This was revealed by the fact that the USP 
Guidelines were not well known among community pharmacists two and one-half years 
after the project had started. However, those who knew about the Guidelines regarded 
them as useful in learning the principles of patient counselling in different settings. 
According to the respondents, the length and comprehensiveness of the Guidelines are 
the greatest barriers to applying them into practice. This may indicate that respondents 
viewed them as an obligatory checklist which has to be covered with every customer. It 
may also point out that learning to use a new tool to customize patient counselling in 
practice is difficult. It seems that practitioners lack reflective skills to evaluate their own 
behaviour and performance. Other studies conducted among Finnish pharmacy 
practitioners indicate the same (Kansanaho et al. 2003, Katajavuori 2005). This finding 
was supported by the fact that the survey respondents did not provide many examples of 
using them in self-evaluation and that they were considered less useful in self-
evaluation than in learning the principles of patient counselling. Also, peer-evaluation 
of performance was the only item in the Delphi questionnaire that did not meet the 
predefined level of acceptance. However, in order to become an expert, reflective skills 
and the ability to evaluate one’s own performance are essential (Katajavuori 2005). 
Critical thinking skills are also needed to understand the larger systems embedded in the 
counselling Guidelines. Pharmacists can e.g., use specific open-ended questions to 
define patient’s information needs or communication style. Pharmacists can also use the 
concepts of health counselling to define their own counselling role (Kansanaho et al. 
2005).  
 There is a need to find a new approach in teaching the pharmacy students and 
working life pharmacists the principles of self- and peer-evaluation. Our study results 
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indicated that pharmacists who had graduated earlier and had more working experience 
knew the guidelines better. This may indicate that pharmacists who have more working 
experience have a better understanding of the evaluation and the reasons for it.   
 The response rate to the questionnaire assessing the use of USP Guidelines was 
moderate. This low response rate may be due to a fact that the survey was conducted 
during the summer time and that it was part of a larger study assessing the 
implementation of the whole project. According to the literature, response rates have 
varied among health care professionals (e.g. doctors, nurses and pharmacists) from 24% 
to 85% (Smith 2002). However, non-response bias must be taken into account when 
interpreting the results. Comparison of the respondent’s characteristics to the target 
population on the basis of mean age, academic degree and geographic location of the 
pharmacy indicated that the study population was representative of the target 
population. In order to gain a deeper understanding of the ways practitioners use the 
Guidelines, focus group discussions or other qualitative methods can be used. 
 The Guidelines should be developed further to make them more applicable in practice 
e.g., by providing shorter modifications. Also, the wordings of the items should be 
changed to better meet the needs of concordance based practices. In the existing version 
of the Guidelines, some of the wording indicate a paternalistic approach to counselling. 
As pharmacists use the Guidelines as the basis for good counselling, the Guidelines 
should reflect the current philosophy of appropriate customer-pharmacist interaction(s). 
The Guidelines have also been integrated into the IPSF (International Pharmaceutical 
Students’ Federation) communication skills booklet (International Pharmaceutical 
Students’ Federation 2005). 
 A pseudo customer method was used as a tool to assess progress in the professional 
content of counselling practice. The pseudo customer method has been used extensively 
in the field of pharmacy practice to assess counselling performance (Willison and 
Muzzin 1995, Watson et al. 2001). The current use of the method is focused on 
promoting a change in behaviour patterns based on the provision of immediate feedback 
after the pseudo customer visit (De Almeida Neto et al. 2001, Berger et al. 2005).  
 The instruments developed in this study can be used as a tool to improve the quality 
of counselling performance. Community pharmacists are aware of the principles of 
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quality assurance e.g., through compounding, but it seems to be difficult to extend these 
principles into professional community pharmacy services such as patient counselling. 
However, some community pharmacies in Finland have extensive quality assurance 
systems and some of the pharmacies are certified based on ISO 9001:2000 standard 
(Association of Finnish Pharmacies 2004). According to a recent study, 64% of the 
pharmacies did systematic quality work (Kivijärvi 2004). Thus, there is a need to 
integrate patient counselling specific instruments into these existing quality assurance 
systems in community pharmacies.  
 
9.2.2 Validity of the instruments 
 
 Most of the instruments in the literature have been developed by academics, which 
may bias instrument development towards research goals which might not directly align 
with actual practice. In this study, we wanted to use the expertise of practicing 
pharmacists in the development process to ensure the practicality of the resulting 
instruments.  
 The validity of the USP Guidelines was assessed by conducting factor analysis. The 
factor analysis was first conducted with varimax as a rotation method. However, there 
were some negative loadings with the three component solution that may be due to high 
correlations between the items of the original scale. Negative loadings can be used in 
analyses just like any other variable, although they will be strongly collinear with the 
measures used to generate them (Nunnally and Bernstein, 1994). This problem was 
solved by using the oblique analytical method of rotation called Oblimin with Kaiser 
Normalization. Oblique analytical methods show a greater variety of methods than do 
orthogonal rotation methods (Nunnally and Bernstein, 1994).  Methodologically this 
solution was the most preferable because the aim was to find a theoretically stable 
solution (Nunnally and Bernstein, 1994).   
 Factor analysis and internal consistency assessment indicated that the USP Guidelines 
are a valid and reliable instrument. One reason for this may be that the USP Guidelines 
were based on a synthesis of several measures developed independently by different 
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institutions and experts. As part of the development process, each measure may have 
been previously subjected to validity and reliability assessments. 
 Assessing inter-rater reliability is also an important part of the validation process.  In 
this study, inter-rater reliability analysis was also conducted by calculating kappa 
values.  However, the use of kappa proved to be problematic. Because we had multiple 
raters and the rating scale ranged from 0-10.  In these conditions, kappa as an indicator 
of inter-rater reliability can be misleading (DeVellis 1991, Rae 1998). Originally, the 
use of kappa was restricted to situations where the number of raters was two and the 
scale was more limited (DeVellis 1991).  In this study, the material used was based on 
pharmacy students’ excellent counselling performances. This may have limited the 
variability on the variable of interest leaving little room for rater disagreement. In 
practice, greater variability in performance is likely to occur. 
 The quality assurance instrument was developed by using a modified Delphi method: 
both expert panels worked as a group to develop the instrument, and the Delphi 
questionnaire was sent to experts after the instrument was constructed. Thus, the 
requirement of anonymity between the members of the panels was not fully 
accomplished, although the responses to the Delphi questionnaire were anonymous. In 
any case, anonymity may reduce the sense of personal responsibility for the end 
product, making participants unaccountable, and deprive them of the potential benefits 
of direct group discussion (Stewart et al. 1999). One strategy to maximise validity of the 
results is to use panels whose members are both experts and have the power to 
implement the decisions if they choose (Cantrill et al. 1996). In Panel 2, some of the 
participants were representatives of the professional pharmacy organisations and 
therefore, had the power to implement and promote the use of the instrument.  Also, 
only one round with the consensus questionnaire was required, as it yielded a high 
consensus, and the participants did not suggest any additional items for the instrument. 
However, the method is flexible, and several modifications have been applied in 
previous studies (Duffield 1993, Stewart et al. 1999, Campbell et al. 2000).  
 In our quality assurance instrument, all the indicators that were accepted had been 
piloted in practice in community pharmacies. The content validity of the instrument 
proved to be good, as a high consensus on the content of the instrument was achieved, 
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and no new dimensions were proposed. The only item that did not meet the predefined 
criteria concerned peer-evaluation. This may partly be explained on the fact that Finnish 
pharmacists are not familiar with peer-evaluation as a method of assessing professional 
performance. However, since peer-evaluation has proved to be an essential part of 
learning and personal development, it was included in the final instrument despite the 
low agreement rate.  
 The use of the modified Delphi method proved to be applicable in the development 
process. We were able to develop a practically oriented instrument that yielded high 
agreement rate among the experts including pharmacy owners and professional 
organisation representatives. This is an important aspect as the pharmacy owners are in 
a key position in the implementation of the instrument. The use of the traditional Delphi 
method may have yielded different results if only the practicing pharmacists attended 
the Delphi questionnaire round after the construction of the instrument by the 
academics.  
 The pseudo customer visits were conducted by a research institute that was also 
responsible for assuring the reliability of the method. During the baseline, structured 
data forms were used to assess the intervention. During the three follow-ups, the 
interactions were also audio-taped. Interactions which were audio-taped were 
transcribed verbatim and analysed. Audio-taping was done to increase the reliability of 
the method. However, as the research company was responsible for quality assurance, 
we do not have exact information about the assessments. In addition, we do not have 
access to the tapes. The pseudo customers were trained according the instructions from 
the TIPPA executive board and the board also developed the scenarios used. 
Furthermore the scenarios were further reviewed by the Department of Pharmacology, 
University of Helsinki to ensure their validity.  
 In our study, the scoring criteria used in the pseudo customer studies were based on 
USP Guidelines and the same criterion was used for both new and repeat prescriptions. 
Reliability assessments of the scoring criteria were not conducted beforehand. A variety 
of scenarios were used, however, it was not possible to cover every therapeutic area or 
scenario. Also more scenarios would have been needed to reflect the whole range of 
drug therapies and pharmacist-customer consultations relevant to them.  
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9.2.3 Counselling practices in community pharmacies during the TIPPA project
   
 Results from the pseudo customer studies during the TIPPA project indicated that 
counselling practices lack a systematic quality approach; counselling received by 
pseudo customers varied a lot depending on the particular scenario used. 
 The prescription scenario was divided into two approaches with new and repeat 
prescription to assess whether any variations occur with these two. Pseudo customers 
presenting a new prescription received some counselling whereas pseudo customers 
with repeat prescriptions received practically no counselling. It appears that pharmacists 
use a prescription’s status as a cue to define customer’s counselling needs. This may 
reflect the fact that pharmacy practitioners do not have a clear understanding of their 
role in supporting patients on long-term therapies and in taking shared responsibility for 
reaching therapeutic outcomes. Pharmacists seem to think that customers on long-term 
medications know how to use their medicines appropriately and they do not need or 
want any information. However, there is evidence that patients with chronic diseases 
need on-going information and support with their drug therapies (Närhi 2002, Jokisalo 
et al. 2002). Furthermore, according to a recent report, only approximately 50% of 
people with chronic conditions in developed countries use their medicines as directed 
(World Health Organisation 2003).  
 Pseudo customers with direct product requests that contain potential iatrogenetic 
interaction received very little counselling. This seems to reflect the fact that 
pharmacists make an assumption about the customers’ information needs based on 
one’s medication (Vainio 2004). Thus, pharmacists generally do not assess patients’ 
needs by asking questions. It appears that the principles of customer-oriented 
counselling are not yet internalized among practitioners. In continuing education 
courses, working-life pharmacists often report that customers asking for products by 
brand name are difficult to handle. These assumptions can be seen in the behaviour 
patterns of pharmacists. It seems that community pharmacists are selling medicines 
instead of treatments. Also, the nature of a direct product request should be taken into 
account: a symptom-based scenario initiates more discussion as the customer needs to 
describe the symptoms instead of just asking for a product (Berger et al. 2005).  
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 The results of pseudo customer studies indicate there is a need for additional 
improvement in existing counselling practices. However, the proportion of pseudo 
customers receiving at least one piece of information increased from 44% at the 
baseline to 61% at the third follow-up. This is a significant change, as previous research 
has shown that the proportion of customers receiving information has remained almost 
stable (approximately 40%) in the 1990s (Airaksinen et al. 1994, Vainio 2004). Even 
though TIPPA was the leading development project taking place in pharmacies at that 
time, we do not know if the changes that occurred were due to TIPPA or to some other 
reason. The formal evaluation of the TIPPA project two and half years after the project 
started determined that pharmacists were very aware of the project and used the 
information tools provided (Varunki 2003, Kansanaho et al. 2005).  However, this kind 
of evaluation was not conducted in the pharmacies taking part in the pseudo customer 
studies.  We know that some individual pharmacies yielded high ratings during the 
pseudo customer studies, but we lack information on the factors that have an impact on 
their performance. These factors may be related e.g., to participation in other quality 
assurance projects, motivation of the pharmacists, commitment of pharmacy owner to 
and intensive continuing education among the pharmacists. These aspects could be 
investigated e.g., by using pseudo customer visits with immediate feedback.  
 Further assessment of the pseudo-customer study results revealed some statistically 
significant differences between study pharmacies and pharmacists (Lahdelma 2005). 
Regardless of the scenario used, most counselling was given in Pirkanmaa area. In 
scenario four (a new prescription), pharmacies with separate booths yielded higher 
ratings than pharmacies with traditional facilities (counter). This may indicate that with 
a modern lay-out that provides more privacy for prescription consultation produces a 
better opportunity for counselling. However, there were no differences with the repeat 
prescription scenario. Furthermore, smaller pharmacies (annual prescription volume 
below 50 000) received higher ratings than bigger pharmacies in scenario three. 
Younger pharmacists (less than 40 years) gave more counselling than older pharmacists 
in scenario two. This may indicate that younger pharmacists are more able to discuss 
gynaecological issues with customers (Lahdelma 2005). However, as these results vary 
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according to the scenarios used, more research is needed on the facilitators of 
counselling practices and actions taken in these individual pharmacies.  
 Changing existing practices is a long-term project and even four years may not be 
long enough. Community pharmacies need to be further supported in their counselling 
development process by e.g., promoting the use of patient counselling specific 
instruments and organising long-term continuing education concerning patient 
counselling. Pharmacists should be encouraged to construct long-term development 
plans to implement good quality patient counselling practice(s). Furthermore 
community pharmacies should be encouraged to continue the quality assurance work 
concerning their professional services. These aspects need to be taken account also in 
basic education. In order to make the improvements arising from the TIPPA project 
durable over time, the profession needs to commit to further development work. The 
new action plans provides a good platform to develop new services and improve the 
professional value of pharmacists in health care.  
 
9.3. Ethical considerations 
 
 Co-operation of study participants, and obtaining data that accurately reflect activities 
and behaviours of individuals under observation are essential for the success of any 
study (Smith 2002). Also, the high quality of the study, correct interpretation and 
reliability of results are considered important ethical principles of scientific research 
(Smith 2002). Study results should be expressed so that individual study participants 
can not be identified.  
 In the survey, the participants had a possibility of not responding. The data have been 
used so that individual pharmacists can not be identified. Citations are used with 
consideration to avoid the identification of individual pharmacists. With the Delphi 
questionnaire the participants had also a possibility not to respond.  
 Before the pseudo customer study was started, all the Finnish community pharmacies 
were informed by the Association of Finnish Pharmacies through a written information 
leaflet. Pharmacies were allowed to deny their participation in the study by informing 
the Association of Finnish Pharmacies, with seven pharmacies refusing. Participating 
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pharmacies were blinded for the scenarios, pseudo customers and time of visits. During 
the project, no reminders were sent. All of the participating pharmacies were given a 
written summary of their performances after the final follow-up was conducted.  
 The material for the validation study was provided by the national Patient 
Counselling Event in the United States. The students’ performances were videotaped 
and the vignettes were used for the study. The students’ consent was obtained for this 
purpose.  
  
9.4 Further research  
 
 More discussion and research are needed to discover the optimum way of influencing 
patient counselling practices in pharmacies. More research is also needed on the 
facilitators of counselling practices and actions taken in these individual pharmacies.  
 The patient counselling specific quality assurance instrument was sent to all 
community pharmacies in the form of a 100-page manual. Further research is needed to 
evaluate the use of the quality assurance instrument in practice. Also, further research is 
required to identify the implications of using the instruments for quality of care. 
 Audio-taped scripts of the pseudo customer visits would give a better understanding 
of the problems in current counselling patterns and the therapeutic information 
discussed. According to our experiences, the data in future studies should be audio-
taped to conduct a more detailed analysis. Also, the pseudo customer method needs to 
be developed further, e.g., to find out the most reliable way of quantitatively scoring the 
interaction. Sensitivity of the measure (i.e., at what point does the measurement 
indicates a change) is crucial for the reliability of the results and therefore, research 
should be conducted to assess this. Also, validity testing of the method should be 
conducted e.g., by comparing the audio-taped scripts with structured data collection 
forms.  
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10 CONCLUSIONS 
 
 Based on the results of this study, the following conclusions can be drawn: 
 
1. Patient counselling instruments developed in this study can be used at different 
levels in the evaluation process: at the organisational and at the individual level. 
2. The quality of patient counselling consists of several dimensions: understanding 
the needs of the customers, personnel training and integrating patient 
counselling into the routine dispensing process. 
3. In order to implement good quality counselling practices, current practices 
should be evaluated in a wider perspective than the customer-pharmacist 
interaction. 
4. The modified Delphi method proved to be applicable in developing a patient 
counselling specific quality assurance instrument. 
5. The USP Medication Counselling Behaviour Guidelines proved to be a valid and 
reliable instrument for evaluating patient counselling practices. 
6. The applicability of the Guidelines was considered less useful for self-evaluation 
than for learning the principles of customer-oriented patient counselling. 
7. The developed pseudo customer method proved to be applicable to making a 
national assessment of the professional content of counselling practices. 
8. The results of the pseudo customer studies indicate that there is still a need to 
improve existing counselling practices.  
9. Based on the methodology employed, validity testing of the USP Guidelines was 
scientifically rigorous. The evidence of their applicability in practices may be 
more limited due to a moderate response rate and the survey method. Even 
though the modified Delphi method was applicable in developing the patient 
counselling specific instrument, this research method is yet to be validated. The 
scoring criteria developed for the pseudo customer studies were not validated 
beforehand.  
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APPENDICES 
  
Appendix 1. USP Medication Counselling Behaviour Guidelines  
    
CATEGORY 1: COUNSELLING INTRODUCTION ITEMS 
CHECKLIST RATING 
Y N N/A  N/A Not Done Poor Unsatisfactory Satisfactory Excellent 
   1. Conducts appropriate counselling introduction by  identifying self and the patient or patient's agent.  0 1 2 3 4 5 6 7 8 9 10 
   2. Explains the purpose of the counseling session.  0 1 2 3 4 5 6 7 8 9 10 
   3. Reviews patient record prior to counseling.  0 1 2 3 4 5 6 7 8 9 10 
   4. Obtains pertinent initial drug related information  (e.g., allergies, other medications, age, etc.).  0 1 2 3 4 5 6 7 8 9 10 
   
5. Warns patient about taking other medications, 
 including OTCs, herbals/botanicals, and alcohol, 
 which could inhibit or interact with the prescribed 
 medication. 
 0 1 2 3 4 5 6 7 8 9 10 
   
6. Determines if the patient has any other medical 
 conditions which could influence the effects of this 
 drug or influence the likelihood of an adverse 
 reaction. 
 0 1 2 3 4 5 6 7 8 9 10 
   7. Assesses the patient's understanding of the reason(s)  for the therapy.  0 1 2 3 4 5 6 7 8 9 10 
   8. Assesses any actual and/or potential concerns or  problems of importance to the patient.  0 1 2 3 4 5 6 7 8 9 10 
 
  
 
CATEGORY 2: COUNSELING CONTENT ITEMS 
CHECKLIST RATING 
Y N N/A  N/A Not Done Poor Unsatisfactory Satisfactory Excellent 
    9.  Discusses the name and indication of the  medication.  0 1 2 3 4 5 6 7 8 9 10 
   10. Explains the dosage regimen, including scheduling  and duration of therapy when appropriate.  0 1 2 3 4 5 6 7 8 9 10 
   
11. Assists the patient in developing a plan to 
 incorporate the medication regimen into his/her 
 daily routine. 
 0 1 2 3 4 5 6 7 8 9 10 
   12. Explains how long it will take for the drug to show  an effect.  0 1 2 3 4 5 6 7 8 9 10 
   13. Discusses storage recommendations, ancillary  instructions  (e.g., shake well, refrigerate, etc.).  0 1 2 3 4 5 6 7 8 9 10 
   14. Tells patient when he/she is due back for a re-fill.  0 1 2 3 4 5 6 7 8 9 10 
   15. Emphasizes the benefits of completing the  medication as prescribed.  0 1 2 3 4 5 6 7 8 9 10 
   16. Discusses potential (significant) side effects.  0 1 2 3 4 5 6 7 8 9 10 
   17. Discusses how to prevent or manage the side effects  of the drug if they do occur.  0 1 2 3 4 5 6 7 8 9 10 
   18. Discusses precautions (activities to avoid, etc.).  0 1 2 3 4 5 6 7 8 9 10 
   19. Discusses significant drug-drug, drug-food, and  drug-disease interactions.  0 1 2 3 4 5 6 7 8 9 10 
   20. Explains in precise terms what to do if the patient  misses a dose.  0 1 2 3 4 5 6 7 8 9 10 
   
21. Explores with the patient potential problems in 
 taking the medication as prescribed (e.g. cost, 
 access, etc.). 
 0 1 2 3 4 5 6 7 8 9 10 
   22. Helps patient generate solutions to potential  problems.  0 1 2 3 4 5 6 7 8 9 10 
   23. Provides accurate information.  0 1 2 3 4 5 6 7 8 9 10 
  
 
CATEGORY 3: COUNSELING PROCESS ITEMS 
CHECKLIST RATING 
Y N N/A  N/A Not Done Poor Unsatisfactory Satisfactory Excellent 
   24. Uses language the patient is likely to understand.  0 1 2 3 4 5 6 7 8 9 10 
   25. Uses appropriate counselling aids to support  counselling.  0 1 2 3 4 5 6 7 8 9 10 
   26. Responds with understanding/empathic responses.  0 1 2 3 4 5 6 7 8 9 10 
   27. Presents facts and concepts in a logical order.  0 1 2 3 4 5 6 7 8 9 10 
   28. Maintains control and direction of the counselling  session.  0 1 2 3 4 5 6 7 8 9 10 
   29. Probes for additional information.  0 1 2 3 4 5 6 7 8 9 10 
   30. Uses open-ended questions.  0 1 2 3 4 5 6 7 8 9 10 
   31. Displays effective nonverbal behaviours:  0 1 2 3 4 5 6 7 8 9 10 
    a. Appropriate eye contact.  0 1 2 3 4 5 6 7 8 9 10 
    b. Voice is audible; tone and pace are good.  0 1 2 3 4 5 6 7 8 9 10 
    c. Body language, postures, and gestures support  the spoken message.  0 1 2 3 4 5 6 7 8 9 10 
    d. Distance between the health care professional  and patient is appropriate.  0 1 2 3 4 5 6 7 8 9 10 
 
 
CATEGORY 4: COUNSELING CONCLUSION ITEMS 
CHECKLIST RATING 
Y N N/A  N/A Not Done Poor Unsatisfactory Satisfactory Excellent 
   32. Verifies patient's understanding, via feedback.  0 1 2 3 4 5 6 7 8 9 10 
   33. Summarizes by acknowledging and/or emphasizing key points of information.  0 1 2 3 4 5 6 7 8 9 10 
   34. Provides an opportunity for final concerns or questions.  0 1 2 3 4 5 6 7 8 9 10 
   35. Helps patient to plan follow-up and next steps.  0 1 2 3 4 5 6 7 8 9 10 
  
Appendix 2. Description of the scenarios and scoring criteria for pseudo customer 
studies 
 
SCENARIO SCORING CRITERIA SCORE 
 
1. Self medication (a product request)  
A customer enters the pharmacy and asks for a 
nasal spray. The medicine is intended for an adult 
suffering from a runny nose and a mild flu. The 
symptoms make it difficult for the customer to 
sleep at night. The customer does not have any 
allergies and has used nasal sprays occasionally. 
 
Needs assessment 
Is the medicine for an adult or a child 
Are the symptoms due to allergy or flu 
Instructions to use 
How to administer the spray into the 
nose 
Harmful effects of long-term use 
Consequences of long-term use 
Score range 
0 – 5 
1 
1 
 
 
1 
1 
1 
 
2. Self medication (a symptom-based request) 
A young (under 25 years) female customer enters 
the pharmacy. She asks medicine for symptoms 
that are related to vaginal fungal infection. She 
has not had any infection before and she has not 
used any fungal medications. The symptoms 
(rush, leucorrhoea) had started a couple of days 
ago. She has just finished taking antibiotics (can’t 
remember the name of the tablets, 10 days course, 
1 tablet per day). She does not take contraceptives 
and she has visited a gynaecologist 2 or 3 years 
ago. 
 
Needs assessment 
What are the symptoms  
If she had experienced the symptoms 
before, were they similar   
Instructions to use 
Administration of the pessary 
Should be taken as a course 
Should be taken at bed time 
If the medicine has not had an effect in 
four days, must visit a doctor 
Score range 
0 – 6 
1 
 
1 
 
1 
1 
1 
 
1 
 
3. Self medication (a direct product request) 
A customer (a young man) enters the pharmacy 
and asks for analgesics by a brand name 
(ketoprofen) and a brand of H2 receptor 
antagonist (ranitidin). The customer has suffered 
from headache for a long time, for which he has 
used ketoprofen, sometimes also ibuprofen or 
aspirin. He has had a prescription for ibuprofen 
600mg which was given to him due to work place 
ergonomics. The doctor had also mentioned a 
possibility of physical treatments, if the symptoms 
would not disappear by adding exercise and 
changing work place ergonomics. The customer 
has not had time to see a physician since; instead 
he has bought analgesics without prescription. He 
consumes 2-3 tablets almost daily. He has been 
taking analgesics for almost six months. Lately he 
has been suffering from stomach ache and 
heartburn (customer implies it is due to stress and 
too much coffee). His colleague has recommended 
this H2 inhibitor and he has decided to try it. The 
customer has not considered seeing a doctor for 
his stomach ache.  
 
Needs assessment 
Are both of the medicines for the 
customer himself  
The reason he is taking these medicines 
How long has he been using analgesics 
How long has he been using ranitidine 
Instructions to use 
Customer is being told about ranitidine 
products: 1-2 tablet per day 
Should be taken as a one week’s course  
If symptoms do not disappear, must 
visit a doctor 
Analgesics  may have caused the 
stomach ache 
Score range 
0 – 8 
 
1 
1 
1 
1 
 
 
1 
1 
 
1 
 
1 
  
Appendix 2. continued 
 
4. Prescription medicine 
A woman (born in 1964) enters the pharmacy with 
a Ventoline® (salbutamol) inhaler prescription.  
The customer has had a cough for a month due to 
flu. At home, her family complaints about her 
coughing at night time. She has used some cough 
medicine that she had at home but it didn’t seem 
to help. Her colleagues made her to see a 
physician and the doctor prescribed Ventoline® 
inhaler, which expands the airways and is usually 
used for the treatment of asthma. The doctor tells 
her to take the medicine regularly for a week and 
after that only for acute symptoms. She can also 
use the cough medicine she has at home, if 
necessary. 
 
Needs assessment 
Has she used the medicine before  
What did the doctor tell her about her 
medication  
Is the drug intended for the treatment of 
asthma 
Instructions to use 
Technical instructions to use the 
inhalator  
Information about how the drug works  
Possible adverse effects were discussed 
Dosage information was given 
Score range 
0 – 7 
1 
 
1 
 
1 
 
 
1 
1 
1 
1 
 
  
Appendix 3. USP questionnaire 
 
USP (United States Pharmacopeia) has developed Medication Counselling Behaviour Guidelines. The 
USP Guidelines consist of 35 items that highlight the basic components of a medication counselling 
session:  1) Introduction; 2) Content; 3) Process Followed; and 4) Conclusion. The aim of the Guidelines 
is to promote two-way communication and customer-oriented patient counselling and they can be used in 
evaluating patient counselling practices.  
 
 
1. How well do you know the Guidelines? 
1. Very well 
2. Quite well 
3. To some extend 
4. Poorly  
5. Not at all  
 
 
2. How did you get to know the Guidelines? 
1. Through basic education 
2. Through continuing education 
3. Through in-house-training 
4. Through  patient counselling and communication skill book 
5. Through something else, describe ___________________________________________ 
 
 
3. Are the USP Guidelines applicable in patient counselling? 
1. Very applicable → answer the question a) 
2. Quite applicable → answer the question a) 
3. Quite poorly applicable → answer the question b) 
4. Very poorly applicable → answer the question b) 
5. Not at all → answer the question b) 
 
a) How have you used to Guidelines in practice? 
b) Why are the Guidelines not applicable in practice? _______________________________ 
 
 
4. How useful are the Guidelines in learning the principles of patient counselling and  
self-evaluation in different settings? 
 Response options:  
 1=Very useful, 2=Quite useful, 3= No opinion, 4=Not useful, 5=Not at all useful 
 
 Principles of   Principles of  
    patient counselling self-evaluation 
 
 In basic education   1  2  3  4  5  1  2  3  4  5 
 In continuing education    1  2  3  4  5  1  2  3  4  5 
 In self learning                  1  2  3  4  5     1  2  3  4  5 
 
 
5. How would you improve the applicability of the Guidelines in patient counselling in practice? 
_________________________________________________________________________________ 
 
 
6. How would you improve the applicability of the Guidelines in self evaluation? 
_________________________________________________________________________________ 
  
DEMOGRAPHIC DATA 
  A.  Age 
   1. < 30 years 
   2. 30-39 years 
   3. 40-49 years 
   4. 50 years and over 
 
  B.  Education 
   1. B.Sc.Pharm.      
   2. M.Sc.Pharm.      
   3.  Other? ____________________________________ 
   4.  Graduation year _____________________________ 
 
  D. Working years in the community pharmacy _________________ 
 
  F. Annual prescription volume in your pharmacy in 2000 
    1. < 30 000 
    2. 30 000−60 000 
    3. 60 001−100 000 
    4. over 100 000 
 
  G. Location of your pharmacy 
    1. Metropolitan area (Helsinki, Espoo, Vantaa, Kauniainen)       
    2.     Other southern part of Finland                                                                    
    3.     Eastern Finland                                       
    4.     Northern Finland (Lapland) 
    5.     Western Finland     
    6. Central Finland 
  
Appendix 4. Delphi questionnaire 
 
The response option are given below, please choose a proper one according to your opinion  
5=totally agree 4=agree 3=I don’t know 2=disagree 1=totally disagree  
       
1. The three dimensions (customer, learning and innovations, process) describe well the quality 
factors of patient counselling 
  
2. In order to assess the needs and expectations of the customers, the following measures can be 
used  
a) assessing the structure of customers   
b) assessing the most common drug therapies used among the customers   
c) systematic collection of customer feedback    
d) using pseudo customers 
    
3. In order to assess the competence of the personnel, the following measures can be used  
a) knowing the principles of customer oriented patient  
b) constructing continuing development plan for the whole pharmacy 
c) constructing continuing development plan for individual pharmacists  
d) sharing patient counselling cased with colleagues   
e) self evaluation of performance    
f) peer evaluation of performance  
g) development discussions concerning patient counselling  
  
       4.  In order to the foster the technical process following measures can be used  
a) ensuring technical skills in processing prescriptions  
b) availability and access to drug information  
c) integration of patient counselling into the dispensing process  
d) Guidelines on the content of patient counselling within the pharmacy  
e) Integration with local health care  
  
 5.  In my opinion, the core idea of patient counselling development plan is the vision of the  
  pharmacy in patient  
 
 6.  In my opinion, the principles of constructing a long-term development plan can be applied in my 
  pharmacy  
  7.  In my opinion the quality manual can be used as a tool to develop the quality of patient  
  counselling in community pharmacies  
 
Please provide feedback about the structure of the manual/measures included 
_____________________________________________________________________________________ 
 
 
Background information: 
 1)   TIPPA-tutor  
 2)  member of the TIPPA executive committee 
 3)  member of the TIPPA executive board 
 4) the employer of the TIPPA tutor´s 
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